menu
    • menu

    Find Rifampicin manufacturers, exporters & distributors on PharmaCompass

    Euroapi Rifampicin

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Synopsis

    Related ProductsRelated Products

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    26

    API Suppliers

    API Suppliers

    10

    USDMF

    US DMFs Filed

    3

    CEP/COS

    CEP/COS Certifications

    1

    JDMF

    JDMFs Filed

    3

    EU WC

    EU WC

    2

    KDMF

    KDMF

    10

    NDC API

    NDC API

    0

    VMF

    NDC API

    11

    Listed Suppliers

    Other Suppliers

    4INTERMEDIATES

    REF. STANDARDS OR IMPURITIES

    2

    EDQM

    0

    USP

    0

    JP

    7

    Others

    FINISHED DOSAGE FORMULATIONS

    191

    FDF Dossiers

    FDF Dossiers

    22

    FDA Orange Book

    FDA (Orange Book)

    83

    Europe

    Europe

    2

    Canada

    Canada

    9

    Australia

    Australia

    55

    South Africa

    South Africa

    20

    Listed Dossiers

    Listed Dossiers

    190DRUGS IN DEVELOPMENT

    FDF Dossiers

    DRUG PRODUCT COMPOSITIONS

    170RELATED EXCIPIENT COMPANIES

    270EXCIPIENTS BY APPLICATIONS

    PATENTS & EXCLUSIVITIES

    0

    US Patents

    0

    US Exclusivities

    0

    Health Canada Patents

    API REF. PRICE (USD/KG)

    $
    $ 205

    GLOBAL SALES INFORMATION

    US Medicaid

    8,353,605

    Annual Reports

    NA

    Regulatory FDF Prices

    Listed Dossiers
    API/FDF Prices: Book a Demo to
    explore the features and consider
    upgrading later

    MARKET PLACE

    23

    API

    9

    FDF

    DIGITAL CONTENT

    1

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    30

    News #PharmaBuzz

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as:
    Molecular Formula
    C43H58N4O12
    Molecular Weight
    822.9  g/mol
    InChI Key
    FZYOVNIOYYPUPY-ZTWDQPHTSA-N
    Rifampicin
    1 2D Structure

    Rifampicin

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z,26E)-2,15,17,29-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[[(4-methylpiperazin-1-yl)amino]methylidene]-6,23,27-trioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,25(29)-heptaen-13-yl] acetate
    2.1.2 InChI
    InChI=1S/C43H58N4O12/c1-21-12-11-13-22(2)42(55)45-33-28(20-44-47-17-15-46(9)16-18-47)37(52)30-31(38(33)53)36(51)26(6)40-32(30)41(54)43(8,59-40)57-19-14-29(56-10)23(3)39(58-27(7)48)25(5)35(50)24(4)34(21)49/h11-14,19-21,23-25,29,34-35,39,44,49-51,53H,15-18H2,1-10H3,(H,45,55)/b12-11+,19-14+,22-13-,28-20+/t21-,23+,24+,25+,29-,34-,35+,39+,43-/m0/s1
    2.1.3 InChI Key
    FZYOVNIOYYPUPY-ZTWDQPHTSA-N
    2.1.4 Canonical SMILES
    CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C(=O)C2=CNN5CCN(CC5)C)O)C
    2.1.5 Isomeric SMILES
    C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C4=C(C(=C3O)C)O[C@@](C4=O)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C(=O)/C2=C/NN5CCN(CC5)C)O)/C
    2.2 Synonyms
    2.2.1 Other Synonyms

    1. Rifomycin S

    2. Rifampicin S

    2.3 Create Date
    2005-03-26
    3 Chemical and Physical Properties
    Molecular Weight 822.9 g/mol
    Molecular Formula C43H58N4O12
    XLogP34
    Hydrogen Bond Donor Count6
    Hydrogen Bond Acceptor Count15
    Rotatable Bond Count5
    Exact Mass822.40512330 g/mol
    Monoisotopic Mass822.40512330 g/mol
    Topological Polar Surface Area217 A^2
    Heavy Atom Count59
    Formal Charge0
    Complexity1750
    Isotope Atom Count0
    Defined Atom Stereocenter Count9
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count4
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 6  
    Drug NameRifadin
    PubMed HealthRifampin (Injection)
    Drug ClassesAntitubercular
    Drug LabelRIFADIN (rifampin capsules USP) for oral administration contain 150 mg or 300 mg rifampin per capsule. The 150 mg and 300 mg capsules also contain, as inactive ingredients: corn starch, D&C Red No. 28, FD&C Blue No. 1, FD&C Red No. 40, gelatin
    Active IngredientRifampin
    Dosage FormCapsule; Injectable
    RouteInjection; Oral
    Strength150mg; 300mg; 600mg/vial
    Market StatusPrescription
    CompanySanofi Aventis Us

    2 of 6  
    Drug NameRifampin
    Active IngredientRifampin
    Dosage FormCapsule; Injectable
    RouteInjection; Oral
    Strength150mg; 300mg; 600mg/vial
    Market StatusPrescription
    CompanyBedford; Lupin Pharms; Sandoz; Emcure Pharms; Fresenius Kabi Usa; Versapharm; Lannett; Agila Speclts

    3 of 6  
    Drug NameRimactane
    PubMed HealthRifampin
    Drug ClassesAntitubercular
    Drug LabelRifampin is a semisynthetic antibiotic derivative of rifamycin SV. Rifampin is a red-brown crystalline powder very slightly soluble in water at neutral pH, freely soluble in chloroform, soluble in ethyl acetate and in methanol. Its molecular weight i...
    Active IngredientRifampin
    Dosage FormCapsule
    RouteOral
    Strength300mg
    Market StatusPrescription
    CompanyProsam Labs

    4 of 6  
    Drug NameRifadin
    PubMed HealthRifampin (Injection)
    Drug ClassesAntitubercular
    Drug LabelRIFADIN (rifampin capsules USP) for oral administration contain 150 mg or 300 mg rifampin per capsule. The 150 mg and 300 mg capsules also contain, as inactive ingredients: corn starch, D&C Red No. 28, FD&C Blue No. 1, FD&C Red No. 40, gelatin
    Active IngredientRifampin
    Dosage FormCapsule; Injectable
    RouteInjection; Oral
    Strength150mg; 300mg; 600mg/vial
    Market StatusPrescription
    CompanySanofi Aventis Us

    5 of 6  
    Drug NameRifampin
    Active IngredientRifampin
    Dosage FormCapsule; Injectable
    RouteInjection; Oral
    Strength150mg; 300mg; 600mg/vial
    Market StatusPrescription
    CompanyBedford; Lupin Pharms; Sandoz; Emcure Pharms; Fresenius Kabi Usa; Versapharm; Lannett; Agila Speclts

    6 of 6  
    Drug NameRimactane
    PubMed HealthRifampin
    Drug ClassesAntitubercular
    Drug LabelRifampin is a semisynthetic antibiotic derivative of rifamycin SV. Rifampin is a red-brown crystalline powder very slightly soluble in water at neutral pH, freely soluble in chloroform, soluble in ethyl acetate and in methanol. Its molecular weight i...
    Active IngredientRifampin
    Dosage FormCapsule
    RouteOral
    Strength300mg
    Market StatusPrescription
    CompanyProsam Labs

    API Reference Price

    read-more
    read-more
    [{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1649183400,"product":"RIFAMPIN USP","address":"Kalpataru Inspire, 3rd floor, off Western Express Highway Santacruz E","city":"Mumbai","supplier":"LUPIN LTD","supplierCountry":"INDIA","foreign_port":"DUBLIN","customer":"GALWAY VASCULAR MFG","customerCountry":"IRELAND","quantity":"10.00","actualQuantity":"10","unit":"KGS","unitRateFc":"200","totalValueFC":"1988.1","currency":"USD","unitRateINR":15000,"date":"06-Apr-2022","totalValueINR":"150000","totalValueInUsd":"1988.1","indian_port":"BOMBAY AIR","hs_no":"29419011","bill_no":"9517078","productDescription":"API","marketType":"REGULATED MARKET","country":"IRELAND","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"Kalpataru Inspire, 3rd floor, off Western Express Highway Santacruz E, Mumbai","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1661711400,"product":"RIFAMPICIN IP\/BP\/EP\/USP (NON COMPACTED)","address":"Kalpataru Inspire, 3rd floor, off Western Express Highway Santacruz E","city":"Mumbai","supplier":"LUPIN LTD","supplierCountry":"INDIA","foreign_port":"CHITTAGONG","customer":"PUBALI BANK LTD","customerCountry":"BANGLADESH","quantity":"9494.90","actualQuantity":"9494.9","unit":"KGS","unitRateFc":"141","totalValueFC":"1321286.4","currency":"USD","unitRateINR":11072.365164456709,"date":"29-Aug-2022","totalValueINR":"105131000","totalValueInUsd":"1321286.4","indian_port":"JNPT","hs_no":"29419011","bill_no":"3830873","productDescription":"API","marketType":"","country":"BANGLADESH","selfForZScoreResived":"Pharma Grade","supplierPort":"JNPT","supplierAddress":"Kalpataru Inspire, 3rd floor, off Western Express Highway Santacruz E, Mumbai","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1673893800,"product":"BULK DRUG : RIFAMPIN USP (RIFAMPICIN)","address":"Kalpataru Inspire, 3rd floor, off Western Express Highway Santacruz E","city":"Mumbai","supplier":"LUPIN LTD","supplierCountry":"INDIA","foreign_port":"NEW YORK","customer":"COOK INC","customerCountry":"UNITED STATES","quantity":"75.00","actualQuantity":"75","unit":"KGS","unitRateFc":"6750","totalValueFC":"507427.5","currency":"USD","unitRateINR":553160,"date":"17-Jan-2023","totalValueINR":"41487000","totalValueInUsd":"507427.5","indian_port":"BOMBAY AIR","hs_no":"29419011","bill_no":"7033039","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"Kalpataru Inspire, 3rd floor, off Western Express Highway Santacruz E, Mumbai","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1674498600,"product":"BULK DRUG : RIFAMPIN USP (RIFAMPICIN)","address":"Kalpataru Inspire, 3rd floor, off Western Express Highway Santacruz E","city":"Mumbai","supplier":"LUPIN LTD","supplierCountry":"INDIA","foreign_port":"NEW YORK","customer":"COOK INC","customerCountry":"UNITED STATES","quantity":"75.00","actualQuantity":"75","unit":"KGS","unitRateFc":"6750","totalValueFC":"498755.7","currency":"USD","unitRateINR":543706.66666666663,"date":"24-Jan-2023","totalValueINR":"40778000","totalValueInUsd":"498755.7","indian_port":"BOMBAY AIR","hs_no":"29419011","bill_no":"7233286","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"Kalpataru Inspire, 3rd floor, off Western Express Highway Santacruz E, Mumbai","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1684693800,"product":"PHARMACEUTICAL RAW MATERIALS RIFAMPICINACTIVE PHARMACEUTICAL INGREDIENTS RIFAMPICIN NON COMPACTED BATCH NO 2380000677","address":"UNIT NO.38, 39 & 40, 3RD FLOOR, PHO PHOENIX MARKET CITY, L.B.S.MARG, KU","city":"MUMBAI","supplier":"OLON ACTIVE PHARMACEUTICAL INGREDIENTS INDIA PRIVA","supplierCountry":"INDIA","foreign_port":"DHAKA","customer":"TO CITI BANK N A","customerCountry":"BANGLADESH","quantity":"550.00","actualQuantity":"550","unit":"KGS","unitRateFc":"133.7","totalValueFC":"72237.4","currency":"USD","unitRateINR":10807.272727272728,"date":"22-May-2023","totalValueINR":"5944000","totalValueInUsd":"72237.4","indian_port":"BOMBAY AIR","hs_no":"29419011","bill_no":"0","productDescription":"API","marketType":"","country":"BANGLADESH","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"UNIT NO.38, 39 & 40, 3RD FLOOR, PHO PHOENIX MARKET CITY, L.B.S.MARG, KU, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1685039400,"product":"BULK DRUG RIFAMPICIN BP EP NON COMPACTED","address":"Kalpataru Inspire, 3rd floor, off Western Express Highway Santacruz E","city":"Mumbai","supplier":"LUPIN LTD","supplierCountry":"INDIA","foreign_port":"DHAKA","customer":"PUBALI BANK LTD","customerCountry":"BANGLADESH","quantity":"230.00","actualQuantity":"230","unit":"KGS","unitRateFc":"150","totalValueFC":"33590.9","currency":"USD","unitRateINR":12017.391304347826,"date":"26-May-2023","totalValueINR":"2764000","totalValueInUsd":"33590.9","indian_port":"BOMBAY AIR","hs_no":"29419011","bill_no":"0","productDescription":"API","marketType":"","country":"BANGLADESH","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"Kalpataru Inspire, 3rd floor, off Western Express Highway Santacruz E, Mumbai","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1708367400,"product":"ACTIVE PHARMACEUTICAL INGREDIENTS RIFAMPICIN (COMPACTED) MATERIAL NO.70100030 CAS NO.13292-46-1.BATCH NOS.2480000178.","address":"UNIT NO. 3B - 38, 39 AND 40,,3RD F","city":"LBS MARG KURLA WEST,MAHARASHTRA","supplier":"OLON ACTIVE PHARMACEUTICAL INGREDIENTS INDIA PRIVA","supplierCountry":"INDIA","foreign_port":"BUCHAREST, OTOPENI","customer":"ANTIBIOTICE S A","customerCountry":"ROMANIA","quantity":"465.30","actualQuantity":"465.3","unit":"KGS","unitRateFc":"250","totalValueFC":"121572.4","currency":"EURO","unitRateINR":21679.178787878787,"date":"20-Feb-2024","totalValueINR":"10087321.89","totalValueInUsd":"121572.4","indian_port":"Bombay Air","hs_no":"29419011","bill_no":"7669846","productDescription":"API","marketType":"","country":"ROMANIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"UNIT NO. 3B - 38, 39 AND 40,,3RD F, LBS MARG KURLA WEST,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1713465000,"product":"ACTIVE PHARMACEUTICAL INGREDIENTS- RIFAMPICIN (COMPACTED) MATERIAL NO.70100030 CAS NO.13292-46-1,","address":"UNIT NO. 3B - 38, 39 AND 40,,3RD F","city":"LBS MARG KURLA WEST,MAHARASHTRA","supplier":"OLON ACTIVE PHARMACEUTICAL INGREDIENTS INDIA PRIVA","supplierCountry":"INDIA","foreign_port":"BUCHAREST","customer":"UNDISCLOSED","customerCountry":"ROMANIA","quantity":"519.30","actualQuantity":"519.3","unit":"KGS","unitRateFc":"250","totalValueFC":"132023","currency":"EURO","unitRateINR":21230.283246678224,"date":"19-Apr-2024","totalValueINR":"11024886.09","totalValueInUsd":"132023","indian_port":"Bombay Air","hs_no":"29419011","bill_no":"9237936","productDescription":"API","marketType":"","country":"ROMANIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"UNIT NO. 3B - 38, 39 AND 40,,3RD F, LBS MARG KURLA WEST,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1729103400,"product":"BULK DRUG : RIFAMPIN USP (NON COMPACTED)(RIFAMPICIN)","address":"159, C.S.T. ROAD,","city":"MUMBAI,MAHARASHTRA","supplier":"LUPIN LTD","supplierCountry":"INDIA","foreign_port":"MEXICO CITY","customer":"VIDARA LIFE INGREDIENTS DE MEXICO S","customerCountry":"MEXICO","quantity":"534.50","actualQuantity":"534.5","unit":"KGS","unitRateFc":"250","totalValueFC":"128200.7","currency":"USD","unitRateINR":20153.90484565014,"date":"17-Oct-2024","totalValueINR":"10772262.14","totalValueInUsd":"128200.7","indian_port":"Bombay Air","hs_no":"29419011","bill_no":"4892209","productDescription":"API","marketType":"","country":"MEXICO","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"159, C.S.T. ROAD,, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1734546600,"product":"BULK DRUG : RIFAMPIN USP (RIFAMPICIN)","address":"159, C.S.T. ROAD,","city":"MUMBAI,MAHARASHTRA","supplier":"LUPIN LTD","supplierCountry":"INDIA","foreign_port":"DUBLIN","customer":"MEDTRONIC VASCULAR GALWAY","customerCountry":"IRELAND","quantity":"10.00","actualQuantity":"10","unit":"KGS","unitRateFc":"10000","totalValueFC":"98741.9","currency":"USD","unitRateINR":839000,"date":"19-Dec-2024","totalValueINR":"8390000","totalValueInUsd":"98741.9","indian_port":"Bombay Air","hs_no":"29419011","bill_no":"6584715","productDescription":"API","marketType":"REGULATED MARKET","country":"IRELAND","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"159, C.S.T. ROAD,, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1734719400,"product":"MATERIAL CODE- 40000402 BATCH NOS.2480005294, 2480005624 ACTIVE PHARMACEUTICAL INGREDIENTS RIFAMPICIN (NON COMPACTED)","address":"UNIT NO. 3B - 38, 39 AND 40,,3RD F","city":"LBS MARG KURLA WEST,MAHARASHTRA","supplier":"OLON ACTIVE PHARMACEUTICAL INGREDIENTS INDIA PRIVA","supplierCountry":"INDIA","foreign_port":"JAKARTA","customer":"UNDISCLOSED","customerCountry":"INDONESIA","quantity":"250.00","actualQuantity":"250","unit":"KGS","unitRateFc":"190","totalValueFC":"46701.2","currency":"USD","unitRateINR":15872.62248,"date":"21-Dec-2024","totalValueINR":"3968155.62","totalValueInUsd":"46701.2","indian_port":"Bombay Air","hs_no":"29419011","bill_no":"6644644","productDescription":"API","marketType":"","country":"INDONESIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"UNIT NO. 3B - 38, 39 AND 40,,3RD F, LBS MARG KURLA WEST,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1735497000,"product":"BULK DRUG : RIFAMPIN USP (RIFAMPICIN)","address":"159, C.S.T. ROAD,","city":"MUMBAI,MAHARASHTRA","supplier":"LUPIN LTD","supplierCountry":"INDIA","foreign_port":"DUBLIN","customer":"MEDTRONIC VASCULAR GALWAY","customerCountry":"IRELAND","quantity":"10.00","actualQuantity":"10","unit":"KGS","unitRateFc":"10000","totalValueFC":"99153.8","currency":"USD","unitRateINR":842500,"date":"30-Dec-2024","totalValueINR":"8425000","totalValueInUsd":"99153.8","indian_port":"Bombay Air","hs_no":"29419011","bill_no":"6885614","productDescription":"API","marketType":"REGULATED MARKET","country":"IRELAND","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"159, C.S.T. ROAD,, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1741285800,"product":"BULK DRUG FREE TRADE SAMPLE HAVING N.C.V.: RIFAMPIN USP (NON COMPACTED) (RIFAMPICIN)","address":"159, C.S.T. ROAD,","city":"MUMBAI,MAHARASHTRA","supplier":"LUPIN LTD","supplierCountry":"INDIA","foreign_port":"BRUSSELS","customer":"GEA PROCESS ENGINEERING NV","customerCountry":"BELGIUM","quantity":"20.00","actualQuantity":"20","unit":"KGS","unitRateFc":"102","totalValueFC":"1965.9","currency":"USD","unitRateINR":8514.0005000000001,"date":"07-Mar-2025","totalValueINR":"170280.01","totalValueInUsd":"1965.9","indian_port":"Bombay Air","hs_no":"29419011","bill_no":"8810637","productDescription":"API","marketType":"REGULATED MARKET","country":"BELGIUM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"159, C.S.T. ROAD,, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1748629800,"product":"BULK DRUG FREE TRADE SAMPLE HAVING N.C.V.: RIFAMPIN USP (NON COMPACTED) (RIFAMPICIN)","address":"159, C.S.T. ROAD,","city":"MUMBAI,MAHARASHTRA","supplier":"LUPIN LTD","supplierCountry":"INDIA","foreign_port":"NEWARK, NJ","customer":"CMIC CMO USA CORP.","customerCountry":"UNITED STATES","quantity":"118.56","actualQuantity":"118.56","unit":"KGS","unitRateFc":"105","totalValueFC":"10300.2","currency":"USD","unitRateINR":7401.9954453441287,"date":"31-May-2025","totalValueINR":"877580.58","totalValueInUsd":"10300.2","indian_port":"Bombay Air","hs_no":"29419011","bill_no":"2318117","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"159, C.S.T. ROAD,, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2025","qtr":"Q3","strtotime":1755714600,"product":"BULK DRUG : RIFAMPIN USP (RIFAMPICIN)","address":"159, C.S.T. ROAD,","city":"MUMBAI,MAHARASHTRA","supplier":"LUPIN LTD","supplierCountry":"INDIA","foreign_port":"DUBLIN","customer":"MEDTRONIC VASCULAR GALWAY","customerCountry":"IRELAND","quantity":"10.00","actualQuantity":"10","unit":"KGS","unitRateFc":"9000","totalValueFC":"89362.7","currency":"USD","unitRateINR":782100,"date":"21-Aug-2025","totalValueINR":"7821000","totalValueInUsd":"89362.7","indian_port":"Bombay Air","hs_no":"29419011","bill_no":"4625917","productDescription":"API","marketType":"REGULATED MARKET","country":"IRELAND","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"159, C.S.T. ROAD,, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1642098600,"product":"RIFAMPICIN IP\/BP","address":"CADILA CORPORATE CAMPUS SARKHEJ-DHOLKA ROAD, BHAT","city":"AHMEDABAD","supplier":"SHENYANG TONGLIAN MEDICINE CO LTD","supplierCountry":"CHINA","foreign_port":"#N\/A","customer":"CADILA PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"66.93","actualQuantity":"66.926","unit":"KGS","unitRateFc":"110","totalValueFC":"7451.5","currency":"USD","unitRateINR":"8294","date":"14-Jan-2022","totalValueINR":"555084.24","totalValueInUsd":"7451.5","indian_port":"JNPT","hs_no":"29419011","bill_no":"7076412","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"#N\/A","supplierAddress":"","customerAddress":"CADILA CORPORATE CAMPUS SARKHEJ-DHOLKA ROAD, BHAT"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1643221800,"product":"RIFAMPICIN IP\/BP","address":"304,ATLANTA ARCADE, MAROL CHURCH RD,ANDHERI EAST Contac","city":"MUMBAI","supplier":"SHENYANG TONGLIAN MEDICINE CO LTD","supplierCountry":"CHINA","foreign_port":"#N\/A","customer":"MACLEODS PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"1557.24","actualQuantity":"1557.239","unit":"KGS","unitRateFc":"160","totalValueFC":"251855.9","currency":"USD","unitRateINR":"12048","date":"27-Jan-2022","totalValueINR":"18761615.47","totalValueInUsd":"251855.9","indian_port":"JNPT","hs_no":"29419030","bill_no":"7244484","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"#N\/A","supplierAddress":"","customerAddress":"304,ATLANTA ARCADE, MAROL CHURCH RD,ANDHERI EAST Contac"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1645122600,"product":"RIFAMPICIN","address":"201, MAHAVIR INDL ESTATE, OFF,MAHA KALI CAVES ROAD, ANDHERI EAST","city":"MUMBAI,MAHARASHTRA","supplier":"SHENYANG TONGLIAN MEDICINE CO LTD","supplierCountry":"CHINA","foreign_port":"","customer":"OXALIS LABS","customerCountry":"INDIA","quantity":"1021.00","actualQuantity":"1021","unit":"KGS","unitRateFc":"150","totalValueFC":"155383.4","currency":"USD","unitRateINR":"11407.5","date":"18-Feb-2022","totalValueINR":"11647057.5","totalValueInUsd":"155383.4","indian_port":"JNPT","hs_no":"29419011","bill_no":"7546067","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"","supplierAddress":"","customerAddress":"201, MAHAVIR INDL ESTATE, OFF,MAHA KALI CAVES ROAD, ANDHERI EAST"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1645122600,"product":"RIFAMPIN USP (ORGANIC CHEMICAL)","address":"PLOT No.30, GALAXY , 1ST MAIN ROAD, J.P. NAGAR, THIRD PH","city":"BENGALURU","supplier":"CKD BIO CORP","supplierCountry":"KOREA, REPUBLIC OF","foreign_port":"NA","customer":"STERISCIENCE SPECIALTIES PRIVATE LTD","customerCountry":"INDIA","quantity":"10.00","actualQuantity":"10","unit":"KGS","unitRateFc":"550","totalValueFC":"6087.5","currency":"USD","unitRateINR":"45630","date":"18-Feb-2022","totalValueINR":"456300","totalValueInUsd":"6087.5","indian_port":"BANGALORE AIR","hs_no":"29419019","bill_no":"7555327","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"PLOT No.30, GALAXY , 1ST MAIN ROAD, J.P. NAGAR, THIRD PH"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1647973800,"product":"RIFAMPICIN IP","address":"CADILA CORPORATE CAMPUS SARKHEJ-DHOLKA ROAD, BHAT","city":"AHMEDABAD","supplier":"LUOHE NANJIECUN PHARMACEUTICAL GROU","supplierCountry":"CHINA","foreign_port":"NA","customer":"CADILA PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"602.86","actualQuantity":"602.859","unit":"KGS","unitRateFc":"160","totalValueFC":"97318.6","currency":"USD","unitRateINR":"12304","date":"23-Mar-2022","totalValueINR":"7417577.14","totalValueInUsd":"97318.6","indian_port":"JNPT","hs_no":"29419011","bill_no":"7974608","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"CADILA CORPORATE CAMPUS SARKHEJ-DHOLKA ROAD, BHAT"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1649183400,"product":"RIFAMPICIN","address":"201, MAHAVIR INDL ESTATE, OFF,MAHA KALI CAVES ROAD, ANDHERI EAST","city":"MUMBAI,MAHARASHTRA","supplier":"SHENYANG TONGLIAN MEDICINE CO LTD","supplierCountry":"CHINA","foreign_port":"NA","customer":"OXALIS LABS","customerCountry":"INDIA","quantity":"381.46","actualQuantity":"381.46","unit":"KGS","unitRateFc":"150","totalValueFC":"58319.5","currency":"USD","unitRateINR":"11535","date":"06-Apr-2022","totalValueINR":"4400141.1","totalValueInUsd":"58319.5","indian_port":"JNPT","hs_no":"29419011","bill_no":"8160447","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"201, MAHAVIR INDL ESTATE, OFF,MAHA KALI CAVES ROAD, ANDHERI EAST"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1652639400,"product":"RIFAMPICIN","address":"201, MAHAVIR INDL ESTATE, OFF,MAHA KALI CAVES ROAD, ANDHERI EAST","city":"MUMBAI,MAHARASHTRA","supplier":"SHENYANG TONGLIAN MEDICINE CO LTD","supplierCountry":"CHINA","foreign_port":"NA","customer":"OXALIS LABS","customerCountry":"INDIA","quantity":"220.92","actualQuantity":"220.92","unit":"KGS","unitRateFc":"190","totalValueFC":"41846.8","currency":"USD","unitRateINR":"14639.5","date":"16-May-2022","totalValueINR":"3234158.34","totalValueInUsd":"41846.8","indian_port":"BOMBAY AIR","hs_no":"29419011","bill_no":"8695834","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"201, MAHAVIR INDL ESTATE, OFF,MAHA KALI CAVES ROAD, ANDHERI EAST"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1652725800,"product":"RIFAMPICIN","address":"236 OKHLA INDUSTRIAL ESTATE, PHASE-3","city":"NEW DELHI","supplier":"LUOHE NANJIECUN PHARMACEUTICAL GROUP PHARMACY CO","supplierCountry":"CHINA","foreign_port":"NA","customer":"ANM PHARMA PRIVATE LTD","customerCountry":"INDIA","quantity":"1287.80","actualQuantity":"1287.8","unit":"KGS","unitRateFc":"163","totalValueFC":"209271.2","currency":"USD","unitRateINR":"12559.2","date":"17-May-2022","totalValueINR":"16173673.37","totalValueInUsd":"209271.2","indian_port":"JNPT","hs_no":"29419011","bill_no":"8718732","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"236 OKHLA INDUSTRIAL ESTATE, PHASE-3"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1662661800,"product":"RIFAMPICIN","address":"201, MAHAVIR INDL ESTATE, OFF,MAHA KALI CAVES ROAD, ANDHERI EAST","city":"MUMBAI,MAHARASHTRA","supplier":"SHENYANG TONGLIAN MEDICINE CO LTD","supplierCountry":"CHINA","foreign_port":"NA","customer":"OXALIS LABS","customerCountry":"INDIA","quantity":"635.90","actualQuantity":"635.9","unit":"KGS","unitRateFc":"165","totalValueFC":"105328","currency":"USD","unitRateINR":"13274.3","date":"09-Sep-2022","totalValueINR":"8441095.58","totalValueInUsd":"105328","indian_port":"JNPT","hs_no":"29419011","bill_no":"2363757","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"201, MAHAVIR INDL ESTATE, OFF,MAHA KALI CAVES ROAD, ANDHERI EAST"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1663785000,"product":"RIFAMPICIN","address":"201, MAHAVIR INDL ESTATE, OFF,MAHA KALI CAVES ROAD, ANDHERI EAST","city":"MUMBAI,MAHARASHTRA","supplier":"SHENYANG TONGLIAN MEDICINE CO LTD","supplierCountry":"CHINA","foreign_port":"NA","customer":"OXALIS LABS","customerCountry":"INDIA","quantity":"3000.00","actualQuantity":"3000","unit":"KGS","unitRateFc":"165","totalValueFC":"496599.4","currency":"USD","unitRateINR":"13266","date":"22-Sep-2022","totalValueINR":"39798000","totalValueInUsd":"496599.4","indian_port":"JNPT","hs_no":"29419011","bill_no":"2557234","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"201, MAHAVIR INDL ESTATE, OFF,MAHA KALI CAVES ROAD, ANDHERI EAST"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1665167400,"product":"RIFAMPICIN USP B.D.0.7 GREEN CARD. 21044 DT.31.07.2020 VLD.31.03.2025, LC NO.0624521FL0000336 DT.25.11.2021 (BATCH NO.8","address":"PLOT NO.D16\/6, TTC INDL.AREA, M.I.D.C., TURBHE,","city":"NAVI MUMBAI, MAHARASHTRA","supplier":"SHENYANG TONGLIAN MEDICINE CO LTD","supplierCountry":"CHINA","foreign_port":"NA","customer":"SVIZERA LABS PRIVATE LTD","customerCountry":"INDIA","quantity":"1000.00","actualQuantity":"1000","unit":"KGS","unitRateFc":"111","totalValueFC":"111223.6","currency":"USD","unitRateINR":"9152","date":"08-Oct-2022","totalValueINR":"9151950","totalValueInUsd":"111223.6","indian_port":"JNPT","hs_no":"29419030","bill_no":"2787692","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"PLOT NO.D16\/6, TTC INDL.AREA, M.I.D.C., TURBHE,"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1672770600,"product":"RIFAMPICIN (AS PER INVOICE)","address":"OFFICE No. 62, 6th FLOOR, TITANIUM CORPORATE ROAD, PRAHALADNAGAR Conta","city":"AHMEDABAD","supplier":"LUOHE NANJIECUN PHARMACEUTICAL GROUP PHARMACY COL","supplierCountry":"CHINA","foreign_port":"NA","customer":"SWISS PARENTERALS LTD","customerCountry":"INDIA","quantity":"153.04","actualQuantity":"153.04","unit":"KGS","unitRateFc":"155","totalValueFC":"24240.7","currency":"USD","unitRateINR":"12950.3","date":"04-Jan-2023","totalValueINR":"1981906.26","totalValueInUsd":"24240.7","indian_port":"AHMEDABAD AIR","hs_no":"29419011","bill_no":"4031909","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"OFFICE No. 62, 6th FLOOR, TITANIUM CORPORATE ROAD, PRAHALADNAGAR Conta"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1674153000,"product":"RIFAMPICIN IP\/BP","address":"N0.104 & 105, MID FORD HOUSE, MIDFORD GARDENS, M.G.ROAD","city":"BANGALORE","supplier":"HEBEI XINGANG PHARMACEUTICAL CO LTD","supplierCountry":"CHINA","foreign_port":"NA","customer":"STERLING LAB","customerCountry":"INDIA","quantity":"1450.00","actualQuantity":"1450","unit":"KGS","unitRateFc":"152.5","totalValueFC":"227038.7","currency":"USD","unitRateINR":"12801.8","date":"20-Jan-2023","totalValueINR":"18562559.25","totalValueInUsd":"227038.7","indian_port":"MADRAS SEA","hs_no":"29419020","bill_no":"4279599","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"N0.104 & 105, MID FORD HOUSE, MIDFORD GARDENS, M.G.ROAD"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1677522600,"product":"RIFAMPICIN","address":"201, MAHAVIR INDL ESTATE, OFF,MAHA KALI CAVES ROAD, ANDHERI EAST","city":"MUMBAI,MAHARASHTRA","supplier":"LUOHE NANJIECUN PHARMACEUTICAL GROU","supplierCountry":"CHINA","foreign_port":"NA","customer":"OXALIS LABS","customerCountry":"INDIA","quantity":"1532.40","actualQuantity":"1532.4","unit":"KGS","unitRateFc":"160","totalValueFC":"248330.7","currency":"USD","unitRateINR":"13384","date":"28-Feb-2023","totalValueINR":"20509641.6","totalValueInUsd":"248330.7","indian_port":"JNPT","hs_no":"29419011","bill_no":"4842704","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"201, MAHAVIR INDL ESTATE, OFF,MAHA KALI CAVES ROAD, ANDHERI EAST"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1680028200,"product":"RIFAMPICIN IP\/BP","address":"G\/6 INDL ESTATE GORWA","city":"VADODARA","supplier":"HEBEI XINGANG PHARMACEUTICAL CO LTDCHINA","supplierCountry":"CHINA","foreign_port":"NA","customer":"CENTURION LABORATORIES PVT LTD","customerCountry":"INDIA","quantity":"320.00","actualQuantity":"320","unit":"KGS","unitRateFc":"152","totalValueFC":"49497.3","currency":"USD","unitRateINR":"12722.4","date":"29-Mar-2023","totalValueINR":"4071168","totalValueInUsd":"49497.3","indian_port":"JNPT","hs_no":"29419090","bill_no":"5282334","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"G\/6 INDL ESTATE GORWA"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1680028200,"product":"RIFAMPICIN IP\/BP","address":"G\/6 INDL ESTATE GORWA","city":"VADODARA","supplier":"HEBEI XINGANG PHARMACEUTICAL CO LTDCHINA","supplierCountry":"CHINA","foreign_port":"NA","customer":"CENTURION LABORATORIES PVT LTD","customerCountry":"INDIA","quantity":"1069.00","actualQuantity":"1069","unit":"KGS","unitRateFc":"152","totalValueFC":"165351.8","currency":"USD","unitRateINR":"12722.4","date":"29-Mar-2023","totalValueINR":"13600245.6","totalValueInUsd":"165351.8","indian_port":"JNPT","hs_no":"29419090","bill_no":"5282334","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"G\/6 INDL ESTATE GORWA"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1696876200,"product":"RIFAMPICIN B.P. (GREEN CARD. 21044 DT.31.07.2020 VLD.31.03.2025)","address":"PLOT NO.D16\/6, TTC INDL.AREA,","city":"NAVI MUMBAI, MAHARASHTRA","supplier":"HEBEI XINGANG PHARMACEUTICAL CO LTD","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"SVIZERA LABS PRIVATE LTD","customerCountry":"INDIA","quantity":"2500.00","actualQuantity":"2500","unit":"KGS","unitRateFc":"168.5","totalValueFC":"425910","currency":"USD","unitRateINR":"14179.3","date":"10-Oct-2023","totalValueINR":"35448187.5","totalValueInUsd":"425910","indian_port":"Bombay Air","hs_no":"29419030","bill_no":"8228338","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"NO.2 FUQIANG STREET ZHAOYUAN ROADZHAO COUNTY SHIJIAZHUANGSDNF CN","customerAddress":"PLOT NO.D16\/6, TTC INDL.AREA,"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1698172200,"product":"RIFAMPICIN USP, EP & BP (IGCRD SR.-A\/2\/333)","address":"SANDOZ HOUSE","city":"MUMBAI ,MAHARASHTRA","supplier":"CKD BIO CORP","supplierCountry":"KOREA, REPUBLIC OF","foreign_port":"SEOUL - INCHEON INT\\'","customer":"SANDOZ PRIVATE LTD","customerCountry":"INDIA","quantity":"2409.00","actualQuantity":"2409","unit":"KGS","unitRateFc":"300","totalValueFC":"731128.9","currency":"USD","unitRateINR":"25260","date":"25-Oct-2023","totalValueINR":"60851340","totalValueInUsd":"731128.9","indian_port":"Bombay Air","hs_no":"29419011","bill_no":"8461866","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"SEOUL - INCHEON INT\\'","supplierAddress":"292, SINWON-RO, DANWON-GU, ANSAN-SI, GY EONGGI-DO Korea, Republic ofSDNF Korea, Republic of","customerAddress":"SANDOZ HOUSE"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1698431400,"product":"RIFAMPICIN","address":"304,ATLANTA ARCADE,","city":"MUMBAI MAHARASHTRA","supplier":"LUOHE NANJIECUN PHARMACEUTICAL GROU","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"MACLEODS PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"1000.00","actualQuantity":"1000","unit":"KGS","unitRateFc":"165","totalValueFC":"167514","currency":"USD","unitRateINR":"13942.1","date":"28-Oct-2023","totalValueINR":"13942072.83","totalValueInUsd":"167514","indian_port":"JNPT","hs_no":"29419011","bill_no":"8515669","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"P PHARMACY CO., LTD,ADDNO 7,RENMINROAD (EAST),LUOHE CITY,HENAN PROVINCE, P.R.CHINA CHINA","customerAddress":"304,ATLANTA ARCADE,"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1699641000,"product":"RIFAMPIN USP","address":"PLOT No.30, GALAXY ,","city":"BENGALURU","supplier":"CKD BIO CORP","supplierCountry":"KOREA, REPUBLIC OF","foreign_port":"SEOUL - INCHEON INT\\'","customer":"STERISCIENCE SPECIALTIES PRIVATE LTD","customerCountry":"INDIA","quantity":"6.00","actualQuantity":"6","unit":"KGS","unitRateFc":"550","totalValueFC":"3840.1","currency":"USD","unitRateINR":"53295","date":"11-Nov-2023","totalValueINR":"319770","totalValueInUsd":"3840.1","indian_port":"Bangalore Air","hs_no":"29419090","bill_no":"8738540","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"SEOUL - INCHEON INT\\'","supplierAddress":"8 CHUNGJEONG-RO SEODAEMUN-GUSEOUL KOREA-03742KOREA KR","customerAddress":"PLOT No.30, GALAXY ,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1707417000,"product":"RIFAMPICIN USP QTY. 27.540 KG AT USD 179.00 PER KG","address":"OFFICE NO.62,SIXTH FLOOR,,TITANIUM","city":"AHMEDABAD,GUJARAT","supplier":"LUOHE NANJIECUN PHARMACEUTICAL GROUP PHARMACY CO","supplierCountry":"CHINA","foreign_port":"HANGCHOW (HANGZHOU)","customer":"DEUTSCHE LABS INC","customerCountry":"INDIA","quantity":"27.54","actualQuantity":"27.54","unit":"KGS","unitRateFc":"179","totalValueFC":"4987.7","currency":"USD","unitRateINR":"15027.1","date":"09-Feb-2024","totalValueINR":"413844.96","totalValueInUsd":"4987.7","indian_port":"Ahmedabad Air","hs_no":"29419011","bill_no":"2062720","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HANGCHOW (HANGZHOU)","supplierAddress":"LTD NO.7, RENMIN ROAD (EAST), LUOHE CITY, HENAN PROVINCE, P.R.CHINASDNF CHINA","customerAddress":"OFFICE NO.62,SIXTH FLOOR,,TITANIUM"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1712860200,"product":"RIFAMPICIN","address":"304,ATLANTA ARCADE,","city":"MUMBAI MAHARASHTRA","supplier":"SINOPHARM INTERNATIONAL HONGKONG LI","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"MACLEODS PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"527.60","actualQuantity":"527.6","unit":"KGS","unitRateFc":"169.5","totalValueFC":"90330.6","currency":"USD","unitRateINR":"14297.3","date":"12-Apr-2024","totalValueINR":"7543268.67","totalValueInUsd":"90330.6","indian_port":"Bombay Air","hs_no":"29419011","bill_no":"3001072","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"MITED ROOM 1601, EMPEROR GROUP CENTER, 288 HENNESSY ROAD,WANCHAI, HONGKONG CHINA","customerAddress":"304,ATLANTA ARCADE,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1713205800,"product":"RIFAMPICIN IP\/BP","address":"G\/6, INDL ESTATE, GORWA","city":"GUJARAT","supplier":"HEBEI XINGANG PHARMACEUTICAL CO LTD","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"CENTURION LABORATORIES PRIVATE LTD","customerCountry":"INDIA","quantity":"2000.00","actualQuantity":"2000","unit":"KGS","unitRateFc":"168","totalValueFC":"339390.7","currency":"USD","unitRateINR":"14170.8","date":"16-Apr-2024","totalValueINR":"28341600","totalValueInUsd":"339390.7","indian_port":"Bombay Air","hs_no":"29419011","bill_no":"3047452","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":".NO.2 FUQIANG STREET, ZHAOYUAN ROADZHAO COUNTRY, SHIJIAZHUANGHEBEI PREOVINCE CHINA","customerAddress":"G\/6, INDL ESTATE, GORWA"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1713465000,"product":"RIFAMPIN USP","address":"PLOT No.30, GALAXY ,","city":"BENGALURU","supplier":"CKD BIO CORP","supplierCountry":"KOREA, REPUBLIC OF","foreign_port":"N\/A","customer":"STERISCIENCE SPECIALTIES PRIVATE LTD","customerCountry":"INDIA","quantity":"25.00","actualQuantity":"25","unit":"KGS","unitRateFc":"550","totalValueFC":"14402.3","currency":"USD","unitRateINR":"48108","date":"19-Apr-2024","totalValueINR":"1202700","totalValueInUsd":"14402.3","indian_port":"Bangalore Air","hs_no":"29419090","bill_no":"3094493","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"N\/A","supplierAddress":"N\/A","customerAddress":"PLOT No.30, GALAXY ,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1713724200,"product":"RIFAMPICIN BP\/IP (GREEN CARD. 21044 DT.31.07.2020 VLD.31.03.2025)","address":"PLOT NO.D16\/6, TTC INDL.AREA,","city":"NAVI MUMBAI, MAHARASHTRA","supplier":"HEBEI XINGANG PHARMACEUTICAL CO LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"SVIZERA LABS PRIVATE LTD","customerCountry":"INDIA","quantity":"4000.00","actualQuantity":"4000","unit":"KGS","unitRateFc":"166","totalValueFC":"671098.2","currency":"USD","unitRateINR":"14010.4","date":"22-Apr-2024","totalValueINR":"56041600","totalValueInUsd":"671098.2","indian_port":"JNPT","hs_no":"29419011","bill_no":"3133118","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"NO.2 FUQIANG STREET ZHAOYUAN ROADZHAO COUNTY SHIJIAZHUANGSDNF CN","customerAddress":"PLOT NO.D16\/6, TTC INDL.AREA,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1714674600,"product":"RIFAMPICIN USP, EP & BP (IGCRD SR.-A\/2\/333)","address":"SANDOZ HOUSE","city":"MUMBAI ,MAHARASHTRA","supplier":"UNDISCLOSED","supplierCountry":"KOREA, REPUBLIC OF","foreign_port":"N\/A","customer":"SANDOZ PRIVATE LTD","customerCountry":"INDIA","quantity":"878.00","actualQuantity":"878","unit":"KGS","unitRateFc":"300","totalValueFC":"266546.8","currency":"USD","unitRateINR":"25305","date":"03-May-2024","totalValueINR":"22217790","totalValueInUsd":"266546.8","indian_port":"Bombay Air","hs_no":"29419011","bill_no":"3323016","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA, REPULIC","selfForZScoreResived":"Pharma Grade","supplierPort":"N\/A","supplierAddress":"N\/A","customerAddress":"SANDOZ HOUSE"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1718130600,"product":"RIFAMPICIN IP","address":"304,ATLANTA ARCADE,","city":"MUMBAI MAHARASHTRA","supplier":"LUOHE NANJIECUN PHARMACEITICALS GRO","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"MACLEODS PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"2000.00","actualQuantity":"2000","unit":"KGS","unitRateFc":"178","totalValueFC":"359499.4","currency":"USD","unitRateINR":"15005.4","date":"12-Jun-2024","totalValueINR":"30010800","totalValueInUsd":"359499.4","indian_port":"Bombay Air","hs_no":"29419011","bill_no":"3953234","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"UP PHARMACY CO LTD. NO.7 EAST RENMIN ROAD,LUOHE HENAN, P.R. CHNASDNF CHINA","customerAddress":"304,ATLANTA ARCADE,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1719167400,"product":"RIFAMPICIN IP\/BP","address":"501-502,AMBA SADAN,","city":"MUMBAI,MAHARASHTRA","supplier":"HEBEI XINGANG PHARMACEUTICAL CO LT","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"GENERAL IMPORT CO INDIA PRIVATE LTD","customerCountry":"INDIA","quantity":"2.07","actualQuantity":"2.065","unit":"KGS","unitRateFc":"166.5","totalValueFC":"347.2","currency":"USD","unitRateINR":"14035.9","date":"24-Jun-2024","totalValueINR":"28984.19","totalValueInUsd":"347.2","indian_port":"JNPT","hs_no":"29419011","bill_no":"4160037","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"D.NO.2 FUQIANG STREET, ZHAOYUAN ROADZHAO COUNTY, SHIJIAZHUANGSDNF CHINA","customerAddress":"501-502,AMBA SADAN,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1719167400,"product":"RIFAMPICIN IP\/BP","address":"501-502,AMBA SADAN,","city":"MUMBAI,MAHARASHTRA","supplier":"HEBEI XINGANG PHARMACEUTICAL CO LT","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"GENERAL IMPORT CO INDIA PRIVATE LTD","customerCountry":"INDIA","quantity":"497.94","actualQuantity":"497.935","unit":"KGS","unitRateFc":"166.5","totalValueFC":"83721.1","currency":"USD","unitRateINR":"14036","date":"24-Jun-2024","totalValueINR":"6988990.76","totalValueInUsd":"83721.1","indian_port":"JNPT","hs_no":"29419011","bill_no":"4160037","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"D.NO.2 FUQIANG STREET, ZHAOYUAN ROADZHAO COUNTY, SHIJIAZHUANGSDNF CHINA","customerAddress":"501-502,AMBA SADAN,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1719599400,"product":"REIMPORT OF ACTIVE PHARMACEUTICAL INGREDIENTS - RIFAMPICIN (NON COMPACTED) (BATCH NO. 2380005358) (FOC)","address":"UNIT NO. 3B - 38, 39 AND 40,,3RD F","city":"LBS MARG KURLA WEST,MAHARASHTRA","supplier":"LINARIA CHEMICALS THAILAND LTD","supplierCountry":"INDIA","foreign_port":"BANGKOK","customer":"OLON ACTIVE PHARMACEUTICAL INGREDIENTS INDIA PRIVA","customerCountry":"INDIA","quantity":"543.30","actualQuantity":"543.3","unit":"KGS","unitRateFc":"175","totalValueFC":"99704","currency":"USD","unitRateINR":"15319.8","date":"29-Jun-2024","totalValueINR":"8323231.93","totalValueInUsd":"99704","indian_port":"Bombay Air","hs_no":"29419011","bill_no":"4249337","productDescription":"Re-Import","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"BANGKOK","supplierAddress":"309 BANGPOO INDUSTRIAL ESTATE,SUKHUMVIT ROAD MOO 4, TUMBOLPHRASKA, AMPUR MUANG, SAMUTPRAKAN,, THAILAND","customerAddress":"UNIT NO. 3B - 38, 39 AND 40,,3RD F"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1720981800,"product":"RIFAMPICIN IP","address":"304,ATLANTA ARCADE,","city":"MUMBAI MAHARASHTRA","supplier":"LUOHE NANJIECUN PHARMACEITICALS GRO","supplierCountry":"CHINA","foreign_port":"SHANGHAI - PU DONG","customer":"MACLEODS PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"2950.00","actualQuantity":"2950","unit":"KGS","unitRateFc":"178","totalValueFC":"530495.6","currency":"USD","unitRateINR":"15032.1","date":"15-Jul-2024","totalValueINR":"44344695","totalValueInUsd":"530495.6","indian_port":"Bombay Air","hs_no":"29419011","bill_no":"4511352","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI - PU DONG","supplierAddress":"UP PHARMACY CO LTD.NO.7 EAST RENMIN ROAD,LUOHE HENAN,P.R. CHNA CHINA","customerAddress":"304,ATLANTA ARCADE,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1721154600,"product":"RIFAMPICIN IP","address":"13,VITHALDAS ROAD,BULAKHIDAS","city":"MUMBAI,MAHARASHTRA","supplier":"HEBEI XINGANG PHARMACEUTICAL CO LTD","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"MEDI PHARMA DRUG HOUSE","customerCountry":"INDIA","quantity":"1000.00","actualQuantity":"1000","unit":"KGS","unitRateFc":"168.1","totalValueFC":"169867.7","currency":"USD","unitRateINR":"14199.4","date":"17-Jul-2024","totalValueINR":"14199423","totalValueInUsd":"169867.7","indian_port":"Bombay Air","hs_no":"29419011","bill_no":"4545239","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"NO 2, FOQIANG STREET, ZHAOYUAN ROAD, ZHAO COUNTY, SHIJIAZHUANG Fuqing,, CHINA CHINA","customerAddress":"13,VITHALDAS ROAD,BULAKHIDAS"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1722277800,"product":"RIFAMPICIN (INVOICE NO : 24HK02EX098FL-CJ-B)","address":"304,ATLANTA ARCADE,","city":"MUMBAI MAHARASHTRA","supplier":"SINOPHARM INTERNATIONAL HONGKONG LI","supplierCountry":"CHINA","foreign_port":"SHANGHAI - PU DONG","customer":"MACLEODS PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"1204.70","actualQuantity":"1204.7","unit":"KGS","unitRateFc":"169.5","totalValueFC":"206539.1","currency":"USD","unitRateINR":"14331.2","date":"30-Jul-2024","totalValueINR":"17264826.76","totalValueInUsd":"206539.1","indian_port":"Bombay Air","hs_no":"29419011","bill_no":"4777387","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI - PU DONG","supplierAddress":"MITED ROOM 1601, EMPEROR GROUP CENTER, 288 HENNESSY ROAD,WANCHAI,HONG KONG CHINA","customerAddress":"304,ATLANTA ARCADE,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1722277800,"product":"RIFAMPICIN (INVOICE NO : 24HK02EX098FL-CJ-B)","address":"304,ATLANTA ARCADE,","city":"MUMBAI MAHARASHTRA","supplier":"SINOPHARM INTERNATIONAL HONGKONG LI","supplierCountry":"CHINA","foreign_port":"SHANGHAI - PU DONG","customer":"MACLEODS PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"3795.30","actualQuantity":"3795.3","unit":"KGS","unitRateFc":"169.5","totalValueFC":"650683.1","currency":"USD","unitRateINR":"14331.2","date":"30-Jul-2024","totalValueINR":"54391298.24","totalValueInUsd":"650683.1","indian_port":"Bombay Air","hs_no":"29419011","bill_no":"4777387","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI - PU DONG","supplierAddress":"MITED ROOM 1601, EMPEROR GROUP CENTER, 288 HENNESSY ROAD,WANCHAI,HONG KONG CHINA","customerAddress":"304,ATLANTA ARCADE,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1724697000,"product":"REIMPORT OF ACTIVE PHARMACEUTICAL INGREDIENTS RIFAMPICIN(NONCOMPACTED)MATERIAL CODE-4000 0402(BATCH NO.2480000156)(FOC)","address":"UNIT NO. 3B - 38, 39 AND 40,,3RD F","city":"LBS MARG KURLA WEST,MAHARASHTRA","supplier":"LINARIA CHEMICALS THAILAND LTD","supplierCountry":"INDIA","foreign_port":"BANGKOK","customer":"OLON ACTIVE PHARMACEUTICAL INGREDIENTS INDIA PRIVA","customerCountry":"INDIA","quantity":"510.00","actualQuantity":"510","unit":"KGS","unitRateFc":"185","totalValueFC":"100118.7","currency":"USD","unitRateINR":"16466.3","date":"27-Aug-2024","totalValueINR":"8397811.32","totalValueInUsd":"100118.7","indian_port":"Bombay Air","hs_no":"29419011","bill_no":"5268421","productDescription":"Re-Import","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"BANGKOK","supplierAddress":"309 BANGPOO INDUSTRIAL ESTATE,SUKHUMVIT ROAD MOO 4, TUMBOLPHRASKA, AMPUR MUANG, SAMUTPRAKAN,, THAILAND","customerAddress":"UNIT NO. 3B - 38, 39 AND 40,,3RD F"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1725820200,"product":"(N.C.V.) RIFAMPICIN PURE (FOR R&D UNIT ONLY)","address":"3RD 4TH FLOORS, H.NO. 5-10-173","city":"HYDERABAD, AP","supplier":"EUROAPI ITALY SRL","supplierCountry":"ITALY","foreign_port":"ROME","customer":"SANOFI HEALTHCARE INDIA PRIVATE LTD","customerCountry":"INDIA","quantity":"50.00","actualQuantity":"50","unit":"KGS","unitRateFc":"380","totalValueFC":"21482.4","currency":"EURO","unitRateINR":"36005","date":"09-Sep-2024","totalValueINR":"1800250","totalValueInUsd":"21482.4","indian_port":"Bombay Air","hs_no":"29419011","bill_no":"5500980","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"ROME","supplierAddress":"VIA ANGELO TITI 22 72100 BRINDISI-B R ITALY Brindisi, , Italy SDNF Italy Italy","customerAddress":"3RD 4TH FLOORS, H.NO. 5-10-173"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1728498600,"product":"RIFAMPICIN BP","address":"PLOT NO. 33, HPSIDC,EXTENSION","city":"BADDI,HIMACHAL PRADESH","supplier":"HEBEI XINGANG PHARMACEUTICAL COLTD","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"HEALER S LAB","customerCountry":"INDIA","quantity":"1600.00","actualQuantity":"1600","unit":"KGS","unitRateFc":"168.5","totalValueFC":"271439.9","currency":"USD","unitRateINR":"14255.1","date":"10-Oct-2024","totalValueINR":"22808160","totalValueInUsd":"271439.9","indian_port":"Delhi Air","hs_no":"29419011","bill_no":"6047160","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"NO.2 FUQIANG STREET,ZHAOYUAN ROAD, ZHAO COUNTRY,SHIJIAZHUANG CHINA ZHA OYUAN, , CHINA CHINA","customerAddress":"PLOT NO. 33, HPSIDC,EXTENSION"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1731349800,"product":"RIFAMPICIN I.P.\/B.P. (GREEN CARD. 21044 DT.31.07.2020 VLD.31.03.2025)","address":"PLOT NO.D16\/6, TTC INDL.AREA,","city":"NAVI MUMBAI, MAHARASHTRA","supplier":"HEBEI XINGANG PHARMACEUTICAL CO LTD","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"SVIZERA LABS PRIVATE LTD","customerCountry":"INDIA","quantity":"2000.00","actualQuantity":"2000","unit":"KGS","unitRateFc":"169","totalValueFC":"341251.6","currency":"USD","unitRateINR":"14398.8","date":"12-Nov-2024","totalValueINR":"28797600","totalValueInUsd":"341251.6","indian_port":"Bombay Air","hs_no":"29419011","bill_no":"6627352","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"NO.2 FUQIANG STREET ZHAOYUAN ROAD ZHAO COUNTY SHIJIAZHUANG SDNF CN","customerAddress":"PLOT NO.D16\/6, TTC INDL.AREA,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1735324200,"product":"RIFAMPICIN I.P.\/B.P. (GREEN CARD. 21044 DT.31.07.2020 VLD.31.03.2025)RIFAMPICIN I.P.\/B.P. (GREEN CARD. 21044 DT.31.07.2020 VLD.31","address":"PLOT NO.D16\/6, TTC INDL.AREA,","city":"NAVI MUMBAI, MAHARASHTRA","supplier":"HEBEI XINGANG PHARMACEUTICAL CO LTD","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"SVIZERA LABS PRIVATE LTD","customerCountry":"INDIA","quantity":"2000.00","actualQuantity":"2000","unit":"KGS","unitRateFc":"169","totalValueFC":"341902.4","currency":"USD","unitRateINR":"14525.6","date":"28-Dec-2024","totalValueINR":"29051100","totalValueInUsd":"341902.4","indian_port":"Bombay Air","hs_no":"29419011","bill_no":"7500063","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"NO.2 FUQIANG STREET ZHAOYUAN ROAD ZHAO COUNTY SHIJIAZHUANG SDNF CN","customerAddress":"PLOT NO.D16\/6, TTC INDL.AREA,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1735497000,"product":"RIFAMPICIN (INV NO.: 24HK01EX129FL-CJ-B) RIFAMPICIN (INV NO.: 24HK01EX129FL-CJ-B)","address":"304,ATLANTA ARCADE,","city":"MUMBAI MAHARASHTRA","supplier":"SINOPHARM INTERNATIONAL HONGK ONG LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"MACLEODS PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"5000.00","actualQuantity":"5000","unit":"KGS","unitRateFc":"166.7","totalValueFC":"842910.5","currency":"USD","unitRateINR":"14324.3","date":"30-Dec-2024","totalValueINR":"71621249","totalValueInUsd":"842910.5","indian_port":"JNPT","hs_no":"29419011","bill_no":"7522266","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"ROOM 1601 EMPEROR GROUP CENTRE, 288 HENNESSY ROAD, W ANCHAI, SDNF HONG KONG","customerAddress":"304,ATLANTA ARCADE,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1736965800,"product":"RIFAMPICIN IP RIFAMPICIN IP","address":"13,VITHALDAS ROAD,BULAKHIDAS","city":"MUMBAI,MAHARASHTRA","supplier":"HEBEI XINGANG PHARMACEUTICAL CO LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"MEDI PHARMA DRUG HOUSE","customerCountry":"INDIA","quantity":"1000.00","actualQuantity":"1000","unit":"KGS","unitRateFc":"165.4","totalValueFC":"166071.1","currency":"USD","unitRateINR":"14320.2","date":"16-Jan-2025","totalValueINR":"14320176","totalValueInUsd":"166071.1","indian_port":"JNPT","hs_no":"29419030","bill_no":"7826563","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"NO 2, FUQIANG STREET, ZHAOYUAN ROAD , ZHAO COUNTY, SHIJIAZHUANG SDNF CHINA","customerAddress":"13,VITHALDAS ROAD,BULAKHIDAS"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1736965800,"product":"RIFAMPICIN IP RIFAMPICIN IP","address":"42,MAHANT ROAD,3,VILE PARLE","city":"MUMBAI,MAHARASHTRA","supplier":"HEBEI XINGANG PHARMACEUTICAL CO L","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"PRATISTHA PHARMA","customerCountry":"INDIA","quantity":"500.00","actualQuantity":"500","unit":"KGS","unitRateFc":"166.6","totalValueFC":"83646.7","currency":"USD","unitRateINR":"14425.6","date":"16-Jan-2025","totalValueINR":"7212790.43","totalValueInUsd":"83646.7","indian_port":"JNPT","hs_no":"29419030","bill_no":"7820536","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"TD. NO.2 FUQIANG STREET ,ZHAOYUAN R OAD, ZHAO COUNTY ,SHIJIAZHUANG, SDNF CHINA","customerAddress":"42,MAHANT ROAD,3,VILE PARLE"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1737311400,"product":"RIFAMPICIN BP RIFAMPICIN BP","address":"11\/B-405 ASISH COMPLEX,","city":"MUMBAI","supplier":"BEIJING ZIZHU PHARM MANAGEMENT CO LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"PESINO PHARMACEUTICALS PRIVATE LTD","customerCountry":"INDIA","quantity":"770.00","actualQuantity":"770","unit":"KGS","unitRateFc":"163","totalValueFC":"126777.5","currency":"USD","unitRateINR":"14197.3","date":"20-Jan-2025","totalValueINR":"10931921","totalValueInUsd":"126777.5","indian_port":"Ahmedabad ICD","hs_no":"29419011","bill_no":"7896972","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"NO.27, CHAOYANG NORTH ROAD,CHAOYANG DISTRICT, BEIJING, CHINA SDNF","customerAddress":"11\/B-405 ASISH COMPLEX,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1737657000,"product":"RIFAMPICIN IP -","address":"167 C S T ROAD KALINA","city":"MUMBAI ,MAHARASHTRA","supplier":"LUOHE CHIEF PHARMACEUTICAL CO LTD","supplierCountry":"CHINA","foreign_port":"EZHOU HUAHU","customer":"CONCEPT PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"200.00","actualQuantity":"200","unit":"KGS","unitRateFc":"174.5","totalValueFC":"35252.4","currency":"USD","unitRateINR":"15199","date":"24-Jan-2025","totalValueINR":"3039790","totalValueInUsd":"35252.4","indian_port":"Delhi Air","hs_no":"29419011","bill_no":"7978088","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"EZHOU HUAHU","supplierAddress":"NO. 168, LONGJIANG ROAD YANCHENG DISTRICT, LUOHE CITY HENAN PROVINCE","customerAddress":"167 C S T ROAD KALINA"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1737657000,"product":"RIFAMPICIN IP -","address":"167 C S T ROAD KALINA","city":"MUMBAI ,MAHARASHTRA","supplier":"LUOHE NANJIECUN PHARMACEUTICAL GROUP PHARMACY CO","supplierCountry":"CHINA","foreign_port":"EZHOU HUAHU","customer":"CONCEPT PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"3000.00","actualQuantity":"3000","unit":"KGS","unitRateFc":"174.5","totalValueFC":"528786.7","currency":"USD","unitRateINR":"15199","date":"24-Jan-2025","totalValueINR":"45596850","totalValueInUsd":"528786.7","indian_port":"Delhi Air","hs_no":"29419011","bill_no":"7964928","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"EZHOU HUAHU","supplierAddress":"LTD. NO. 7, RENMIN ROAD (EAST), LUOHE CITY, HENAN PROVINCE, P.R.,","customerAddress":"167 C S T ROAD KALINA"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1740076200,"product":"RIFAMPICIN IP (BD NOT LESS THAN 0.7) RIFAMPICIN IP (BD NOT LESS THAN 0.7)","address":"M-15, D- 2 D-3, INDUSTRIAL AREA,","city":"SONEPAT \/HRY","supplier":"HEBEI XINGANG PHARMACEUTICAL CO LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"COMBITIC GLOBAL CAPLET PRIVATE LTD","customerCountry":"INDIA","quantity":"900.00","actualQuantity":"900","unit":"KGS","unitRateFc":"173","totalValueFC":"157107.1","currency":"USD","unitRateINR":"15180.8","date":"21-Feb-2025","totalValueINR":"13662675","totalValueInUsd":"157107.1","indian_port":"JNPT","hs_no":"29419011","bill_no":"8480154","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"NO.2 FUQIANG STREET ZHAOYU ROAD, ZHAO COUNTRY, SHIJIAZHUANG, HEBEI PROVINCE, CHINA","customerAddress":"M-15, D- 2 D-3, INDUSTRIAL AREA,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1740767400,"product":"RIFAMPICIN I.P.\/B.P. (GREEN CARD. 21044 DT.31.07.2020 VLD.31.03.2025)RIFAMPICIN I.P.\/B.P. (GREEN CARD. 21044 DT.31.07.2020 VLD.31","address":"PLOT NO.D16\/6, TTC INDL.AREA,","city":"NAVI MUMBAI, MAHARASHTRA","supplier":"HEBEI XINGANG PHARMACEUTICAL CO LTD","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"SVIZERA LABS PRIVATE LTD","customerCountry":"INDIA","quantity":"3800.00","actualQuantity":"3800","unit":"KGS","unitRateFc":"169","totalValueFC":"650596","currency":"USD","unitRateINR":"14829.8","date":"01-Mar-2025","totalValueINR":"56353050","totalValueInUsd":"650596","indian_port":"Bombay Air","hs_no":"29419011","bill_no":"8636797","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"NO.2 FUQIANG STREET ZHAOYUAN ROAD ZHAO COUNTY SHIJIAZHUANG SDNF CN","customerAddress":"PLOT NO.D16\/6, TTC INDL.AREA,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1741026600,"product":"RIFAMPICIN IP RIFAMPICIN IP","address":"304,ATLANTA ARCADE,","city":"MUMBAI MAHARASHTRA","supplier":"LUOHE NANJIECUN PHARMACEUTICAL GROUP PHARMACY CO","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"MACLEODS PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"5000.00","actualQuantity":"5000","unit":"KGS","unitRateFc":"169","totalValueFC":"856047.3","currency":"USD","unitRateINR":"14829.8","date":"04-Mar-2025","totalValueINR":"74148750","totalValueInUsd":"856047.3","indian_port":"JNPT","hs_no":"29419011","bill_no":"8688223","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"LTD NO.7, RENMIN ROAD (EAST), LUOHE CITY,HENAN PROVINCE, P.R. SDNF CHINA","customerAddress":"304,ATLANTA ARCADE,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1741199400,"product":"RIFAMPICIN RIFAMPICIN","address":"SURVEY NO.144 146, VILLAGE","city":"DIST.VADODARA, GUJARAT","supplier":"LUOHE CHIEF PHARMACEUTICAL CO LTD","supplierCountry":"CHINA","foreign_port":"CHENGDU","customer":"BHARAT PARENTERALS LTD","customerCountry":"INDIA","quantity":"852.93","actualQuantity":"852.93","unit":"KGS","unitRateFc":"170","totalValueFC":"146893.8","currency":"USD","unitRateINR":"14917.5","date":"06-Mar-2025","totalValueINR":"12723583.28","totalValueInUsd":"146893.8","indian_port":"Bombay Air","hs_no":"29419011","bill_no":"8733072","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"CHENGDU","supplierAddress":".NO.168, LONG JIANG ROAD,YANCHENG D ISTRICT LUOHE CITY,HENAM PROVINCE, SDNF CHINA","customerAddress":"SURVEY NO.144 146, VILLAGE"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1741458600,"product":"RIFAMPICIN IP -","address":"167 C S T ROAD KALINA","city":"MUMBAI ,MAHARASHTRA","supplier":"LUOHE CHIEF PHARMACEUTICAL CO LTD","supplierCountry":"CHINA","foreign_port":"ZHENGZHOU","customer":"CONCEPT PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"5000.00","actualQuantity":"5000","unit":"KGS","unitRateFc":"174.5","totalValueFC":"884410.5","currency":"USD","unitRateINR":"15321.1","date":"09-Mar-2025","totalValueINR":"76605500","totalValueInUsd":"884410.5","indian_port":"Delhi Air","hs_no":"29419011","bill_no":"8787632","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"ZHENGZHOU","supplierAddress":"NO. 168, LONGJIANG ROAD YANCHENG DISTRICT, LUOHE CITY HENAN PROVINCE, CHINA","customerAddress":"167 C S T ROAD KALINA"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1741631400,"product":"RIFAMPICIN IP RIFAMPICIN IP","address":"13,VITHALDAS ROAD,BULAKHIDAS","city":"MUMBAI,MAHARASHTRA","supplier":"HEBEI XINGANG PHARMACEUTICAL CO LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"MEDI PHARMA DRUG HOUSE","customerCountry":"INDIA","quantity":"1000.00","actualQuantity":"1000","unit":"KGS","unitRateFc":"165.4","totalValueFC":"167617.3","currency":"USD","unitRateINR":"14518.6","date":"11-Mar-2025","totalValueINR":"14518608","totalValueInUsd":"167617.3","indian_port":"JNPT","hs_no":"29419011","bill_no":"8833177","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"NO 2, FUQIANG STREET, ZHAOYUAN ROAD , ZHAO COUNTY, SHIJIAZHUANG SDNF CHINA","customerAddress":"13,VITHALDAS ROAD,BULAKHIDAS"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1743618600,"product":"RIFAMPICIN IP\/BP B.D.0.7 -","address":"167 C S T ROAD KALINA","city":"MUMBAI ,MAHARASHTRA","supplier":"ZHEJIANG CHEMICALS IMPORT AND EXPORT CORP","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"CONCEPT PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"600.00","actualQuantity":"600","unit":"KGS","unitRateFc":"163","totalValueFC":"99740.2","currency":"USD","unitRateINR":"14229.9","date":"03-Apr-2025","totalValueINR":"8537940","totalValueInUsd":"99740.2","indian_port":"Delhi Air","hs_no":"29419011","bill_no":"9274935","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"10F, BUILDING 4, TAIPING FINANCE TOWER, NO.199 SHIMIN STREET, SHANGCHENG DISTRICT, HANGZHOU, CHINA","customerAddress":"167 C S T ROAD KALINA"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1743964200,"product":"RIFAMPICIN IP RIFAMPICIN IP","address":"159, C.S.T. ROAD,","city":"MUMBAI,MAHARASHTRA","supplier":"HEBEI XINGANG PHARMACEUTICAL COLTD","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"LUPIN LTD","customerCountry":"INDIA","quantity":"500.00","actualQuantity":"500","unit":"KGS","unitRateFc":"185.5","totalValueFC":"93856.5","currency":"USD","unitRateINR":"16068.6","date":"07-Apr-2025","totalValueINR":"8034281","totalValueInUsd":"93856.5","indian_port":"Bombay Air","hs_no":"29419011","bill_no":"9344137","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"NO.2, FUQIANG STREET, ZHAOYUAN ROAD , ZHAO COUNTY, SHIJIAZHUANG. HEBEI PROVINCE, CHINA 051530 China","customerAddress":"159, C.S.T. ROAD,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1745519400,"product":"RIFAMPICIN RIFAMPICIN","address":"304,ATLANTA ARCADE,","city":"MUMBAI MAHARASHTRA","supplier":"ZHEJIANG CHEMICALS IMPOR AND EXPORT","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"MACLEODS PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"2000.00","actualQuantity":"2000","unit":"KGS","unitRateFc":"163","totalValueFC":"329039.9","currency":"USD","unitRateINR":"14083.2","date":"25-Apr-2025","totalValueINR":"28166400","totalValueInUsd":"329039.9","indian_port":"Bombay Air","hs_no":"29419011","bill_no":"9705370","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"CORPORATION 10F, BUILDING 4, TAIPIN G FINANCE TOWER, NO.199 SHIMIN STRE ET, SHANGCHENG DISTRICT, HANGZHOU, CHINA","customerAddress":"304,ATLANTA ARCADE,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1745778600,"product":"RIFAMPICIN RIFAMPICIN","address":"304,ATLANTA ARCADE,","city":"MUMBAI MAHARASHTRA","supplier":"ZHEJIANG CHEMICALS IMPOR AND EXPORT","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"MACLEODS PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"3744.95","actualQuantity":"3744.95","unit":"KGS","unitRateFc":"163","totalValueFC":"616119","currency":"USD","unitRateINR":"14083.2","date":"28-Apr-2025","totalValueINR":"52740879.84","totalValueInUsd":"616119","indian_port":"Bombay Air","hs_no":"29419011","bill_no":"9750254","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"CORPORATION 10F, BUILDING 4, TAIPIN G FINANCE TOWER, NO.199 SHIMIN STRE ET, SHANGCHENG DISTRICT, HANGZHOU, CHINA","customerAddress":"304,ATLANTA ARCADE,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1746210600,"product":"RIFAMPICIN RIFAMPICIN","address":"304,ATLANTA ARCADE,","city":"MUMBAI MAHARASHTRA","supplier":"ZHEJIANG CHEMICALS IMPOR AND EXPORT","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"MACLEODS PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"2000.00","actualQuantity":"2000","unit":"KGS","unitRateFc":"163","totalValueFC":"327336.7","currency":"USD","unitRateINR":"13944.7","date":"03-May-2025","totalValueINR":"27889300","totalValueInUsd":"327336.7","indian_port":"Bombay Air","hs_no":"29419011","bill_no":"9858412","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"CORPORATION 10F, BUILDING 4, TAIPIN G FINANCE TOWER, NO.199 SHIMIN STRE ET, SHANGCHENG DISTRICT, HANGZHOU, CHINA","customerAddress":"304,ATLANTA ARCADE,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1746556200,"product":"RIFAMPICIN IP IUPAC NAME:[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15-17,27,29-PENTAHYDROXY-11-METHOXY-3,7,12,1RIFAMPICIN IP IUPAC NAME:[(7S,9E,11S,12R,13S,14R,15R,16R,17S","address":"159, C.S.T. ROAD,","city":"MUMBAI,MAHARASHTRA","supplier":"HEBEI XINGANG PHARMACEUTICAL COLTD","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"LUPIN LTD","customerCountry":"INDIA","quantity":"2000.00","actualQuantity":"2000","unit":"KGS","unitRateFc":"176.6","totalValueFC":"354648.3","currency":"USD","unitRateINR":"15108.1","date":"07-May-2025","totalValueINR":"30216266","totalValueInUsd":"354648.3","indian_port":"JNPT SEZ\/MUMBAI","hs_no":"29419011","bill_no":"9916404","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"NO.2, FUQIANG STREET, ZHAOYUAN ROAD , ZHAO COUNTY, SHIJIAZHUANG HEBEI PROVINCE, CHINA 051530 China","customerAddress":"159, C.S.T. ROAD,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1746556200,"product":"RIFAMPIN USP","address":"ZYDUS CORPORATE PARK, SCHEME NO. 63, SURVEY NO. 536","city":"AHMEDABAD","supplier":"CKD BIO CORP","supplierCountry":"KOREA, REPUBLIC OF","foreign_port":"INCHEON INTL APT\/SEO","customer":"ZYDUS PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"475.00","actualQuantity":"475","unit":"KGS","unitRateFc":"300","totalValueFC":"143084.3","currency":"USD","unitRateINR":"25665","date":"07-May-2025","totalValueINR":"12190875","totalValueInUsd":"143084.3","indian_port":"Ahmedabad-ZIPL-SEZ","hs_no":"29419090","bill_no":"9919497","productDescription":"API","marketType":"REGULATED MARKET","country":"REPUBLIC OF KOREA","selfForZScoreResived":"Pharma Grade","supplierPort":"INCHEON INTL APT\/SEO","supplierAddress":"292, SINWON -RO DANWON GU, ANSAN-SI GYEONGGI-DO SDNF KOREA,REPUBLIC OF","customerAddress":"ZYDUS CORPORATE PARK, SCHEME NO. 63, SURVEY NO. 536"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1746729000,"product":"RIFAMPICIN RIFAMPICIN","address":"304,ATLANTA ARCADE,","city":"MUMBAI MAHARASHTRA","supplier":"HEBEI XINGANG PHARMACEUTICAL CO LT","supplierCountry":"CHINA","foreign_port":"CHENGDU","customer":"MACLEODS PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"290.95","actualQuantity":"290.95","unit":"KGS","unitRateFc":"167","totalValueFC":"48778.1","currency":"USD","unitRateINR":"14284","date":"09-May-2025","totalValueINR":"4155926.73","totalValueInUsd":"48778.1","indian_port":"Bombay Air","hs_no":"29419011","bill_no":"9961887","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"CHENGDU","supplierAddress":"D. NO.2 FUQIANG STREET, ZHAOYUAN RO AD, ZHAO COUTY, SHIJIAZHUANG CHINA SDNF CHINA","customerAddress":"304,ATLANTA ARCADE,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1746729000,"product":"RIFAMPICIN RIFAMPICIN","address":"304,ATLANTA ARCADE,","city":"MUMBAI MAHARASHTRA","supplier":"HEBEI XINGANG PHARMACEUTICAL CO LT","supplierCountry":"CHINA","foreign_port":"CHENGDU","customer":"MACLEODS PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"3179.05","actualQuantity":"3179.05","unit":"KGS","unitRateFc":"167","totalValueFC":"532971.5","currency":"USD","unitRateINR":"14284","date":"09-May-2025","totalValueINR":"45409516.65","totalValueInUsd":"532971.5","indian_port":"Bombay Air","hs_no":"29419011","bill_no":"9961887","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"CHENGDU","supplierAddress":"D. NO.2 FUQIANG STREET, ZHAOYUAN RO AD, ZHAO COUTY, SHIJIAZHUANG CHINA SDNF CHINA","customerAddress":"304,ATLANTA ARCADE,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1746729000,"product":"RIFAMPICIN RIFAMPICIN","address":"SURVEY NO.144 146, VILLAGE","city":"DIST.VADODARA, GUJARAT","supplier":"LUOHE CHIEF PHARMACEUTICAL CO LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"BHARAT PARENTERALS LTD","customerCountry":"INDIA","quantity":"2426.63","actualQuantity":"2426.63","unit":"KGS","unitRateFc":"170","totalValueFC":"414218.6","currency":"USD","unitRateINR":"14543.5","date":"09-May-2025","totalValueINR":"35291693.41","totalValueInUsd":"414218.6","indian_port":"JNPT","hs_no":"29419011","bill_no":"9955268","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":".NO.168, LONG JIANG ROAD,YANCHENG D ISTRICT LUOHE CITY,HENAN PROVINCE, SDNF CHINA","customerAddress":"SURVEY NO.144 146, VILLAGE"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1747593000,"product":"RIFAMPICIN IP IUPAC NAME:[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15-17,27,29-PENTAHYDROXY-11-METHOXY-3,7,12,1RIFAMPICIN IP IUPAC NAME:[(7S,9E,11S,12R,13S,14R,15R,16R,17S","address":"159, C.S.T. ROAD,","city":"MUMBAI,MAHARASHTRA","supplier":"HEBEI XINGANG PHARMACEUTICAL COLTD","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"LUPIN LTD","customerCountry":"INDIA","quantity":"2000.00","actualQuantity":"2000","unit":"KGS","unitRateFc":"176.6","totalValueFC":"358170","currency":"USD","unitRateINR":"15258.2","date":"19-May-2025","totalValueINR":"30516316","totalValueInUsd":"358170","indian_port":"JNPT SEZ\/MUMBAI","hs_no":"29419011","bill_no":"2151279","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"NO.2, FUQIANG STREET, ZHAOYUAN ROAD , ZHAO COUNTY, SHIJIAZHUANG HEBEI PROVINCE, CHINA 051530 China","customerAddress":"159, C.S.T. ROAD,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1748197800,"product":"RIFAMPICIN USP (5 DRUMS 125 KGS) RIFAMPICIN USP (5 DRUMS 125 KGS)","address":"304, SAMAAN-II, OPP. RELIANCE","city":"GARDEN SATELLITE, AHMEDABAD-GUJARAT","supplier":"ZHEJIANG CHEMICALS IMPORT","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"SWISS PARENTERALS LTD","customerCountry":"INDIA","quantity":"6.88","actualQuantity":"6.884","unit":"KGS","unitRateFc":"163","totalValueFC":"1137.9","currency":"USD","unitRateINR":"14083.2","date":"26-May-2025","totalValueINR":"96948.75","totalValueInUsd":"1137.9","indian_port":"Ahmedabad Air","hs_no":"29419011","bill_no":"2290890","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"AND EXPORT CORPORATION, 10F , BUILDING 4, TAIPING FINANCE TOWER , NO.199, SHIMIN STREET, SHANGCHENG CHINA","customerAddress":"304, SAMAAN-II, OPP. RELIANCE"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1749148200,"product":"RIFAMPICIN IP RIFAMPICIN IP","address":"304,ATLANTA ARCADE,","city":"MUMBAI MAHARASHTRA","supplier":"LUOHE NANJIECUN PHARMACEUTICAL GROUP PHARMACY CO","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"MACLEODS PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"5000.00","actualQuantity":"5000","unit":"KGS","unitRateFc":"169","totalValueFC":"853109","currency":"USD","unitRateINR":"14660.8","date":"06-Jun-2025","totalValueINR":"73303750","totalValueInUsd":"853109","indian_port":"JNPT","hs_no":"29419011","bill_no":"2494423","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"LTD NO.7, RENMIN ROAD (EAST), LUOHE CITY,HENAN PROVINCE, P.R.CHINA SDNF CHINA","customerAddress":"304,ATLANTA ARCADE,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1749234600,"product":"RIFAMPICIN IP BP ((GREEN CARD. 21338 DT.15.04.2025 VLD.31.03.2030)RIFAMPICIN IP BP ((GREEN CARD. 21338 DT.15.04.2025 VLD.31.03","address":"PLOT NO.D16\/6, TTC INDL.AREA,","city":"NAVI MUMBAI, MAHARASHTRA","supplier":"UNDISCLOSED","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"SVIZERA LABS PRIVATE LTD","customerCountry":"INDIA","quantity":"2000.00","actualQuantity":"2000","unit":"KGS","unitRateFc":"163","totalValueFC":"329128.5","currency":"USD","unitRateINR":"14140.3","date":"07-Jun-2025","totalValueINR":"28280500","totalValueInUsd":"329128.5","indian_port":"Bombay Air","hs_no":"29419011","bill_no":"2522246","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"NF","customerAddress":"PLOT NO.D16\/6, TTC INDL.AREA,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1749493800,"product":"RIFAMPICIN IP RIFAMPICIN IP","address":"A 407,ANJANI COMPLEX, OPP GURUNANAK","city":"CHAKALA, ANDHERI EAST, MUMBAI","supplier":"ZHEJIANG CHEMICALS IMPORT AND EXPORT CORP","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"IMEX OVERSEAS","customerCountry":"INDIA","quantity":"500.00","actualQuantity":"500","unit":"KGS","unitRateFc":"160","totalValueFC":"80767.7","currency":"USD","unitRateINR":"13880","date":"10-Jun-2025","totalValueINR":"6940000","totalValueInUsd":"80767.7","indian_port":"JNPT","hs_no":"29419011","bill_no":"2564768","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"10F , BUILDING 4, TAIPING FINANCE T OWER, NO.199 SHIMIN STREET, SHANGCH ENG DISTRICT, HANGZHOU, CHINA CHIN CHINA","customerAddress":"A 407,ANJANI COMPLEX, OPP GURUNANAK"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q3","strtotime":1752172200,"product":"RIFAMPICIN IP\/BP (GREEN CARD. 21338 DT.15.04.2025 VLD.31.03.2030)RIFAMPICIN IP\/BP (GREEN CARD. 21338 DT.15.04.2025 VLD.31.03.","address":"PLOT NO.D16\/6, TTC INDL.AREA,","city":"NAVI MUMBAI, MAHARASHTRA","supplier":"HEBEI XINGANG PHARMACEUTICAL CO LTD","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"SVIZERA LABS PRIVATE LTD","customerCountry":"INDIA","quantity":"2000.00","actualQuantity":"2000","unit":"KGS","unitRateFc":"167","totalValueFC":"334520.3","currency":"USD","unitRateINR":"14395.4","date":"11-Jul-2025","totalValueINR":"28790800","totalValueInUsd":"334520.3","indian_port":"Bombay Air","hs_no":"29419011","bill_no":"3197616","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"NO.2 FUQIANG STREET ZHAOYUAN ROAD ZHAO COUNTY SHIJIAZHUANG SDNF CN","customerAddress":"PLOT NO.D16\/6, TTC INDL.AREA,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q3","strtotime":1752777000,"product":"RIFAMPICIN IP\/BP (GREEN CARD. 21338 DT.15.04.2025 VLD.31.03.2030)RIFAMPICIN IP\/BP (GREEN CARD. 21338 DT.15.04.2025 VLD.31.03.","address":"PLOT NO.D16\/6, TTC INDL.AREA,","city":"NAVI MUMBAI, MAHARASHTRA","supplier":"HEBEI XINGANG PHARMACEUTICAL CO LTD","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"SVIZERA LABS PRIVATE LTD","customerCountry":"INDIA","quantity":"2000.00","actualQuantity":"2000","unit":"KGS","unitRateFc":"167","totalValueFC":"336848.8","currency":"USD","unitRateINR":"14495.6","date":"18-Jul-2025","totalValueINR":"28991200","totalValueInUsd":"336848.8","indian_port":"Bombay Air","hs_no":"29419011","bill_no":"3337325","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"NO.2 FUQIANG STREET ZHAOYUAN ROAD ZHAO COUNTY SHIJIAZHUANG SDNF CN","customerAddress":"PLOT NO.D16\/6, TTC INDL.AREA,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q3","strtotime":1753727400,"product":"RIFAMPICIN BP RIFAMPICIN BP","address":"NO.54-55, INDUSTRIAL AREA,","city":"CHANDIGARH.","supplier":"HEPTAD BIOTECH LTD","supplierCountry":"CHINA","foreign_port":"HANGCHOW (HANGZHOU)","customer":"SCOTT EDIL PHARMACIA LTD","customerCountry":"INDIA","quantity":"500.00","actualQuantity":"500","unit":"KGS","unitRateFc":"164.7","totalValueFC":"83067.5","currency":"USD","unitRateINR":"14298.6","date":"29-Jul-2025","totalValueINR":"7149282","totalValueInUsd":"83067.5","indian_port":"Delhi Air","hs_no":"29419090","bill_no":"3554496","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HANGCHOW (HANGZHOU)","supplierAddress":"3109 EXCELLENCE CENTER 1258 HAIDE 3RD ROAD YUEHAI STREET SDNF CHINA","customerAddress":"NO.54-55, INDUSTRIAL AREA,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q3","strtotime":1754418600,"product":"RIFAMPICIN IP RIFAMPICIN IP","address":"159, C.S.T. ROAD,","city":"MUMBAI,MAHARASHTRA","supplier":"HEBEI XINGANG PHARMACEUTICAL CO LTD","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"LUPIN LTD","customerCountry":"INDIA","quantity":"3500.00","actualQuantity":"3500","unit":"KGS","unitRateFc":"178.9","totalValueFC":"620957.5","currency":"USD","unitRateINR":"15527.4","date":"06-Aug-2025","totalValueINR":"54346010.8","totalValueInUsd":"620957.5","indian_port":"Bombay Air","hs_no":"29419011","bill_no":"3719134","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"NO.2, FUQIANG STREET, ZHAOYUAN ROAD , ZHAO COUNTY, SHIJIAZHUANG, HEBEI PROVINCE, CHINA 051530 China","customerAddress":"159, C.S.T. ROAD,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q3","strtotime":1755455400,"product":"COLISTIMETHATE SODIUM BATCH NO CMSG2504007 RIFAMPIN USP","address":"NO.138-B, UDAYAGIRI COMPLEX, KIADB","city":"BANGALORE","supplier":"LIVZON GROUP FUZHOU FUXING PHARMACEUTICAL CO LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"ONESOURCE SPECIALTY PHARMA LTD","customerCountry":"INDIA","quantity":"25.00","actualQuantity":"25","unit":"KGS","unitRateFc":"5600","totalValueFC":"141728.1","currency":"USD","unitRateINR":"496160","date":"18-Aug-2025","totalValueINR":"12404000","totalValueInUsd":"141728.1","indian_port":"Bangalore Air","hs_no":"29419090","bill_no":"3946542","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"NO.8 NANGANG ROAD, FUQING JIANGYIN INDUSTRIAL ZONE FUZHOU CITY, CHINA CN","customerAddress":"NO.138-B, UDAYAGIRI COMPLEX, KIADB"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q3","strtotime":1756060200,"product":"RIFAMPICIN IP2022 RIFAMPICIN IP2022","address":"218\/219, 2ND FLOOR,KAILASH PLAZA,","city":"GHATKOPAR EAST,MUMBAI, MAHARASTHRA","supplier":"HEBEI XINGANG PHARMACEUTICAL COLTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"AQUATIC REMEDIES LTD","customerCountry":"INDIA","quantity":"1000.00","actualQuantity":"1000","unit":"KGS","unitRateFc":"167.1","totalValueFC":"167836.2","currency":"USD","unitRateINR":"14689","date":"25-Aug-2025","totalValueINR":"14688972.55","totalValueInUsd":"167836.2","indian_port":"Bombay Air","hs_no":"29419011","bill_no":"4085166","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"NO. 2 FUQIANG STREET, ZHAOYUAN ROAD , ZHAO COUNTY, SHUIAZHUANG CHINA SDNF CHINA","customerAddress":"218\/219, 2ND FLOOR,KAILASH PLAZA,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q3","strtotime":1757615400,"product":"RIFAMPIN USP BATCH NO: RIFP250060 RIFAMPIN USP BATCH NO: RIFP250060","address":"564\/A\/22, ROAD NO.92","city":"HYDERABAD,ANDHRA PRADESH","supplier":"CKD BIO CORP","supplierCountry":"KOREA, REPUBLIC OF","foreign_port":"SEOUL - INCHEON INT\\'","customer":"MYLAN LABORATORIES LTD","customerCountry":"INDIA","quantity":"14.00","actualQuantity":"14","unit":"KGS","unitRateFc":"550","totalValueFC":"7763.8","currency":"USD","unitRateINR":"48950","date":"12-Sep-2025","totalValueINR":"685300","totalValueInUsd":"7763.8","indian_port":"Bangalore Air","hs_no":"29419011","bill_no":"4465105","productDescription":"API","marketType":"REGULATED MARKET","country":"REPUBLIC OF KOREA","selfForZScoreResived":"Pharma Grade","supplierPort":"SEOUL - INCHEON INT\\'","supplierAddress":"8 CHUNGJEONG-RO, SEODAEMUN-GU SEOUL KOREA-03742, SOUTH KOREA SDNF Korea, Republic of","customerAddress":"564\/A\/22, ROAD NO.92"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q3","strtotime":1758479400,"product":"RIFAMPICIN BP RIFAMPICIN BP","address":"NO.54-55, INDUSTRIAL AREA,","city":"CHANDIGARH.","supplier":"HANGZHOU DAWN RAY PHARMACEUTICAL","supplierCountry":"CHINA","foreign_port":"CHENGDU","customer":"SCOTT EDIL PHARMACIA LTD","customerCountry":"INDIA","quantity":"700.00","actualQuantity":"700","unit":"KGS","unitRateFc":"161.7","totalValueFC":"113913.8","currency":"USD","unitRateINR":"14364.4","date":"22-Sep-2025","totalValueINR":"10055065.65","totalValueInUsd":"113913.8","indian_port":"Delhi Air","hs_no":"29419090","bill_no":"4663574","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"CHENGDU","supplierAddress":"CO.LTD 1613 GUANGYIN BLDG NO.42 E FENGQI ROAD HANGZHOU 310012 SDNF CHINA","customerAddress":"NO.54-55, INDUSTRIAL AREA,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q4","strtotime":1760293800,"product":"RIFAMPICIN IP RIFAMPICIN IP","address":"NO 28","city":"BOMBAY ,MAHARASHTRA","supplier":"ZHEJIANG CHEMICALS IMPORT AND EXPORT CORP","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"RUSKIN CHEMIPHARM","customerCountry":"INDIA","quantity":"1000.00","actualQuantity":"1000","unit":"KGS","unitRateFc":"130","totalValueFC":"131955.9","currency":"USD","unitRateINR":"11661","date":"13-Oct-2025","totalValueINR":"11661000","totalValueInUsd":"131955.9","indian_port":"JNPT","hs_no":"29419011","bill_no":"5063255","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"10F , BUILDING 4, TAIPING FINANCE T OWER, NO.199 SHIMIN STREET, SHANGCH ENG DISTRICT, HANGZHOU, CHINA CHI CHINA","customerAddress":"NO 28"}]
    14-Jan-2022
    13-Oct-2025
    KGS
    overview
    Loading...

    Average Price (USD/KGS)

    Number of Transactions

    Total Quantity (KGS)

    Total Value (USD)

    Quantity (KGS) & Unit rate (USD/KGS) over time

    API/FDF Prices: Book a Demo to explore the features and consider upgrading later

    API Imports and Exports

    Importing Country Total Quantity
    (KGS)    		 Average Price
    (USD/KGS)    		 Number of Transactions

    Upgrade, download data, analyse, strategize, subscribe with us contact

    Drugs in Development

    read-more
    read-more
    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Effect of Rifampicin on the Pharmacokinetics and Pharmacodynamics of Sotagliflozin

    Details:

    Sotagliflozin is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Diabetes Mellitus.


    Lead Product(s): Sotagliflozin,Rifampicin

    Therapeutic Area: Endocrinology Brand Name: Undisclosed

    Study Phase: Phase IProduct Type: Miscellaneous

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable February 24, 2017

    Sanofi Company Banner

    01

    Sanofi

    France
    arrow
    AES
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Lead Product(s) : Sotagliflozin,Rifampicin

    Therapeutic Area : Endocrinology

    Highest Development Status : Phase I

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Effect of Rifampicin on the Pharmacokinetics and Pharmacodynamics of Sotagliflozin

    Details : Sotagliflozin is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Diabetes Mellitus.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    February 24, 2017

    Sanofi Company Banner

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    A Study to Assess the Effect of Rifampin on the Metabolism of ABT-199

    Details:

    Venetoclax is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Lymphoma, Non-Hodgkin.


    Lead Product(s): Venetoclax,Rifampicin

    Therapeutic Area: Oncology Brand Name: Undisclosed

    Study Phase: Phase IProduct Type: Miscellaneous

    Sponsor: Genentech

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable October 25, 2013

    Abbvie Company Banner

    02

    AbbVie Inc

    U.S.A
    arrow
    AES
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Venetoclax,Rifampicin

    Therapeutic Area : Oncology

    Highest Development Status : Phase I

    Partner/Sponsor/Collaborator : Genentech

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    A Study to Assess the Effect of Rifampin on the Metabolism of ABT-199

    Details : Venetoclax is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Lymphoma, Non-Hodgkin.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    October 25, 2013

    Abbvie Company Banner

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    A Study to Assess the Effect of Rifampin on the Metabolism of Navitoclax

    Details:

    Navitoclax is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Leukemia, Lymphoid.


    Lead Product(s): Navitoclax,Rifampicin

    Therapeutic Area: Oncology Brand Name: Undisclosed

    Study Phase: Phase IProduct Type: Miscellaneous

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable May 12, 2010

    Abbvie Company Banner

    03

    AbbVie Inc

    U.S.A
    arrow
    AES
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Navitoclax,Rifampicin

    Therapeutic Area : Oncology

    Highest Development Status : Phase I

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    A Study to Assess the Effect of Rifampin on the Metabolism of Navitoclax

    Details : Navitoclax is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Leukemia, Lymphoid.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    May 12, 2010

    Abbvie Company Banner

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    A Study to Evaluate the Effect of Itraconazole and Rifampin on the Drug Levels of AR-LDD (BMS-986365) in Healthy Adult Male Participants

    Details:

    BMS-986365 is a PROTACs drug candidate, which is currently being evaluated in Phase I clinical studies for the treatment of undefined medical condition.


    Lead Product(s): BMS-986365,Itraconazole,Rifampicin

    Therapeutic Area: Undisclosed Brand Name: Undisclosed

    Study Phase: Phase IProduct Type: PROTACs

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable November 21, 2025

    blank

    04

    Bristol Myers Squibb

    U.S.A
    arrow
    AES
    Not Confirmed

    Bristol Myers Squibb

    U.S.A
    arrow
    AES
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : BMS-986365,Itraconazole,Rifampicin

    Therapeutic Area : Undisclosed

    Highest Development Status : Phase I

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    A Study to Evaluate the Effect of Itraconazole and Rifampin on the Drug Levels of AR-LDD (BMS-9863...

    Details : BMS-986365 is a PROTACs drug candidate, which is currently being evaluated in Phase I clinical studies for the treatment of undefined medical condition.

    Product Name : Undisclosed

    Product Type : PROTACs

    Upfront Cash : Inapplicable

    November 21, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Short-term Antibiotic Therapy in Mycobacterium Avium Complex Pulmonary Disease

    Details:

    Contezolid is a small molecule drug candidate, which is currently being evaluated in Phase IV clinical studies for the treatment of Mycobacterium Avium Complex Pulmonary Disease.


    Lead Product(s): Contezolid,Azithromycin,Ethambutol,Rifampicin

    Therapeutic Area: Pulmonary/Respiratory Diseases Brand Name: Undisclosed

    Study Phase: Phase IVProduct Type: Miscellaneous

    Sponsor: Bin Cao | Shanghai Pulmonary Hospital | Beijing Chest Hospital | Anhui Chest Hospital | Jiangxi Chest Hospital | Guangzhou Chest Hospital.

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable October 09, 2025

    blank

    05

    MicuRx Pharmaceuticals

    U.S.A
    arrow
    AES
    Not Confirmed

    MicuRx Pharmaceuticals

    U.S.A
    arrow
    AES
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Contezolid,Azithromycin,Ethambutol,Rifampicin

    Therapeutic Area : Pulmonary/Respiratory Diseases

    Highest Development Status : Phase IV

    Partner/Sponsor/Collaborator : Bin Cao | Shanghai Pulmonary Hospital | Beijing Chest Hospital | Anhui Chest Hospital | Jiangxi Chest Hospital | Guangzhou Chest Hospital.

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Short-term Antibiotic Therapy in Mycobacterium Avium Complex Pulmonary Disease

    Details : Contezolid is a small molecule drug candidate, which is currently being evaluated in Phase IV clinical studies for the treatment of Mycobacterium Avium Complex Pulmonary Disease.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    October 09, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific

    Details:

    Elutia will leverage its proven drug-eluting biologics platform with a more concentrated focus on advancing NXT-41x, a biomatrix that directly addresses the root causes of reconstruction infections.


    Lead Product(s): Rifampicin,Minocycline Hydrochloride

    Therapeutic Area: Infections and Infectious Diseases Brand Name: EluPro

    Study Phase: Approved FDFProduct Type: Antibiotic

    Sponsor: Boston Scientific

    Deal Size: $88.0 million Upfront Cash: $88.0 million

    Deal Type: Divestment October 01, 2025

    blank

    06

    Elutia

    U.S.A
    arrow
    AES
    Not Confirmed

    Elutia

    U.S.A
    arrow
    AES
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Rifampicin,Minocycline Hydrochloride

    Therapeutic Area : Infections and Infectious Diseases

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Boston Scientific

    Deal Size : $88.0 million

    Deal Type : Divestment

    DEALS_DEV arrow-down

    Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific

    Details : Elutia will leverage its proven drug-eluting biologics platform with a more concentrated focus on advancing NXT-41x, a biomatrix that directly addresses the root causes of reconstruction infections.

    Product Name : EluPro

    Product Type : Antibiotic

    Upfront Cash : $88.0 million

    October 01, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding (RADIO-TB Trial)

    Details:

    Isoniazid is a Small Molecule drug candidate drug candidate, which is currently being evaluated in Phase III clinical studies for the treatment of Tuberculosis.


    Lead Product(s): Isoniazid,Rifampicin,Pyrazinamide,Ethambutol

    Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed

    Study Phase: Phase IIIProduct Type: Miscellaneous

    Sponsor: National University of Medical Sciences, Pakistan | Aurum Institute | Biomedical Research and Training Institute, Zimbabwe | Foundation for Innovative New Diagnostics, Switzerland | KTH Royal Institute of Technology | London School of Hygiene & Tropical M

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable September 09, 2025

    blank

    07

    University College, London

    Country
    arrow
    AES
    Not Confirmed

    University College, London

    Country
    arrow
    AES
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Isoniazid,Rifampicin,Pyrazinamide,Ethambutol

    Therapeutic Area : Infections and Infectious Diseases

    Highest Development Status : Phase III

    Partner/Sponsor/Collaborator : National University of Medical Sciences, Pakistan | Aurum Institute | Biomedical Research and Training Institute, Zimbabwe | Foundation for Innovative New Diagnostics, Switzerland | KTH Royal Institute of Technology | London School of Hygiene & Tropical M

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identi...

    Details : Isoniazid is a Small Molecule drug candidate drug candidate, which is currently being evaluated in Phase III clinical studies for the treatment of Tuberculosis.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    September 09, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Effect of Rifampicin on PK of HSK31858 in Healthy Subjects

    Details:

    HSK31858 is a Other Small Molecule drug candidate, which is currently being evaluated in Phase I clinical studies for the treatment of unspecified medical condition.


    Lead Product(s): HSK31858,Rifampicin

    Therapeutic Area: Undisclosed Brand Name: Undisclosed

    Study Phase: Phase IProduct Type: Miscellaneous

    Sponsor: Undisclosed

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable August 21, 2025

    blank

    08

    Haisco Pharmaceutical

    China
    arrow
    AES
    Not Confirmed

    Haisco Pharmaceutical

    China
    arrow
    AES
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : HSK31858,Rifampicin

    Therapeutic Area : Undisclosed

    Highest Development Status : Phase I

    Partner/Sponsor/Collaborator : Undisclosed

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Effect of Rifampicin on PK of HSK31858 in Healthy Subjects

    Details : HSK31858 is a Other Small Molecule drug candidate, which is currently being evaluated in Phase I clinical studies for the treatment of unspecified medical condition.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    August 21, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Shorter Rifampicin-Based Treatment in Less Severe Tuberculosis

    Details:

    Rifampicin is a Antibiotic drug candidate, which is currently being evaluated in Phase III clinical studies for the treatment of Tuberculosis, Pulmonary.


    Lead Product(s): Rifampicin,Inapplicable

    Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed

    Study Phase: Phase IIIProduct Type: Antibiotic

    Sponsor: St George's, University of London | McMaster University

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable August 12, 2025

    blank

    09

    Hamilton Health Sciences

    Canada
    arrow
    AES
    Not Confirmed

    Hamilton Health Sciences

    Canada
    arrow
    AES
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Rifampicin,Inapplicable

    Therapeutic Area : Infections and Infectious Diseases

    Highest Development Status : Phase III

    Partner/Sponsor/Collaborator : St George's, University of London | McMaster University

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Shorter Rifampicin-Based Treatment in Less Severe Tuberculosis

    Details : Rifampicin is a Antibiotic drug candidate, which is currently being evaluated in Phase III clinical studies for the treatment of Tuberculosis, Pulmonary.

    Product Name : Undisclosed

    Product Type : Antibiotic

    Upfront Cash : Inapplicable

    August 12, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Short-term Bactericidal Effect of Contezolid in MAC-PD

    Details:

    Contezolid is a Other Small Molecule drug candidate, which is currently being evaluated in Phase IV clinical studies for the treatment of Mycobacterium Avium Complex Pulmonary Disease.


    Lead Product(s): Contezolid,Azithromycin,Rifampicin,Ethambutol

    Therapeutic Area: Pulmonary/Respiratory Diseases Brand Name: Undisclosed

    Study Phase: Phase IVProduct Type: Miscellaneous

    Sponsor: Beijing Chest Hospital, Capital Medical University | Jiangxi Provincial Chest Hospital | Bin Cao

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable July 24, 2025

    blank

    10

    MicuRx Pharmaceuticals

    U.S.A
    arrow
    AES
    Not Confirmed

    MicuRx Pharmaceuticals

    U.S.A
    arrow
    AES
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Contezolid,Azithromycin,Rifampicin,Ethambutol

    Therapeutic Area : Pulmonary/Respiratory Diseases

    Highest Development Status : Phase IV

    Partner/Sponsor/Collaborator : Beijing Chest Hospital, Capital Medical University | Jiangxi Provincial Chest Hospital | Bin Cao

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Short-term Bactericidal Effect of Contezolid in MAC-PD

    Details : Contezolid is a Other Small Molecule drug candidate, which is currently being evaluated in Phase IV clinical studies for the treatment of Mycobacterium Avium Complex Pulmonary Disease.

    Product Name : Undisclosed

    Product Type : Miscellaneous

    Upfront Cash : Inapplicable

    July 24, 2025

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Related Excipient Companies

    Upload your portfolio for free, ask us

    Excipients by Applications

    Click here to find the perfect excipient manufacturers by their capabilities

    Fillers, Diluents & Binders

    read-more
    read-more

    Thickeners and Stabilizers

    read-more
    read-more

    Granulation

    read-more
    read-more

    Direct Compression

    read-more
    read-more

    Lubricants & Glidants

    read-more
    read-more

    Disintegrants & Superdisintegrants

    read-more
    read-more

    Coating Systems & Additives

    read-more
    read-more

    Co-Processed Excipients

    read-more
    read-more

    Solubilizers

    read-more
    read-more

    Controlled & Modified Release

    read-more
    read-more

    Taste Masking

    read-more
    read-more

    Film Formers & Plasticizers

    read-more
    read-more

    Empty Capsules

    read-more
    read-more

    Chewable & Orodispersible Aids

    read-more
    read-more

    Rheology Modifiers

    read-more
    read-more

    Emulsifying Agents

    read-more
    read-more

    Parenteral

    read-more
    read-more

    Topical

    read-more
    read-more

    Coloring Agents

    read-more
    read-more

    API Stability Enhancers

    read-more
    read-more

    Surfactant & Foaming Agents

    read-more
    read-more

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    DATA COMPILATION #PharmaFlow

    read-more
    read-more
    US drug shortages reduce 16% YoY in Q1 2025; CNS drugs, antimicrobials face highest scarcities

    US drug shortages reduce 16% YoY in Q1 2025; CNS drugs, antimicrobials face highest scarcities

    The pharmaceutical industry in the United States continued to grapple with drug shortages during the first quarter (Q1) of 2025. According to the American Society of Health‑System Pharmacists (ASHP), the total number of active shortages stood at 270 as of March 31, 2025 — only slightly below the 277 reported in September 2024, but down 16.4 percent from an all‑time high of 323 reported in Q1 2024.These numbers imply that while dramatic surges in drug shortages may have subsided, underlying vulnerabilities in manufacturing, supply chains, and raw‑material sourcing continue to frustrate efforts towards a durable resolution.A deeper analysis of these drug scarcities reveals that 41 percent of the 270 active shortages first emerged in 2022 or earlier. This implies that many of the current disruptions have become chronic in nature and are exerting pressure on pharmacy operations. View Our Interactive Dashboard on Drug Shortages So Far in 2025 (Free Excel Available)CNS drugs dominate with 49 meds in short supply; antimicrobials face shortage of 39 drugsClass‑specific analysis reveals that central nervous system (CNS) agents remained the most disrupted category, with 49 distinct CNS drugs having faced scarcities during Q1. This group spans anxiolytics (anti-anxiety drugs) such as clonazepam and flurazepam, sedatives like lorazepam and midazolam, and stimulants such as methylphenidate and lisdexamfetamine. These shortages pose two challenges — controlling seizures and managing sedation in acute care settings. After CNS agents, antimicrobials was the second‑largest category, with shortages affecting 39 drugs. Key antibacterial and anti-fungal agents such as cefotaxime sodium powder for injection, clindamycin phosphate, rifampin, and metronidazole find themselves on ASHP’s active‑shortage roster, threatening both routine hospital protocols and emergency sepsis management.Fluids and electrolytes occupied the third spot, with 29 items facing shortage in Q1 2025. Hormone agents, including insulin analogs, ranked fourth with 24 drugs in short supply.Chemotherapy medications rounded out the top five categories, with 23 antineoplastic agents (a broad class of medications used to treat cancer) flagged as actively constrained in Q1 2025. Notable shortages included azacitidine, carboplatin, methotrexate, and streptozocin. View Our Interactive Dashboard on Drug Shortages So Far in 2025 (Free Excel Available) US faces 26 new shortages; Pharmacopeia list warns of 100 vulnerable medicationsThe first quarter saw the emergence of 26 new shortage declarations, emphasizing that even drugs previously deemed reliably sourced can fall into scarcity. The US has been facing a shortage of attention deficit hyperactivity disorder (ADHD) drugs since 2022. The new shortages included ADHD transdermal patch methylphenidate, peginterferon alfa‑2a (Pegasys) used in chronic hepatitis B and C, and bacitracin ophthalmic ointment.The fragility of the pharmaceutical supply chains has been particularly evident in the aftermath of natural disasters. Hurricane Helene’s flooding at Baxter’s Marion, North Carolina, facility deeply affected IV‑solution supply lines. Baxter supplies roughly 60 percent of the US’ IV fluids and the ASHP report listed “hurricane” as the reason behind nine percent of drug shortages, as of January 2025.Regulatory and policy interventions continue to evolve. The US Pharmacopeia’s inaugural Vulnerable Medicines List, launched in 2025, identifies 100 drugs at the highest risk of future shortages, with a particular focus on injectables (comprising 71 percent of the list) and essential hospital care.Antibiotics, medications for pain management and oncology are the other drugs on the list. Although 61 percent of these vulnerable medicines were not in active shortage at the time of listing, their inclusion is intended to galvanize manufacturers and purchasing organizations to bolster inventories.Meanwhile, the Government Accountability Office in the US has called on the Department of Health and Human Services (HHS) to establish a formal coordination mechanism, warning that elimination of the HHS supply‑chain coordinator role in May 2025 risks fragmenting federal response efforts. View Our Interactive Dashboard on Drug Shortages So Far in 2025 (Free Excel Available) Global shortages mirror US patterns; Europe launches monitoring platform Globally, we notice comparable trends. For instance, Europe has rolled out the European Shortages Monitoring Platform (ESMP) this year in order to centralize shortage reporting across member states. Critical‑medicine shortages in the EU — in areas such as oncology, ADHD, and critical care analgesics — mirror US patterns. The European Medicines Agency’s shortage list currently holds 37 human drugs.According to Health Canada’s May 12, 2025 update, its Tier 3 list had 18 drug shortages that are considered to have the greatest impact on Canada’s drug supply and health‑care system. Tier 3 designation is based on medical necessity and minimal availability of alternatives.In hematology and oncology, scarcity of essential drugs like Oncaspar for acute lymphoblastic leukemia, idarubicin and lomustine for leukemias and brain tumors, anagrelide for thrombocythemia, and preservative‑free methotrexate for various malignancies underscore the impact these drug shortages can have on treatment. View Our Interactive Dashboard on Drug Shortages So Far in 2025 (Free Excel Available) Our viewThe global pharma supply chain is dealing with a fresh wave of uncertainties, especially with the likelihood of tariffs on drugs imported into the US. Analysts warn that the proposed pharmaceutical tariffs could exacerbate supply issues.Over 50 percent of drugs used in the US are manufactured abroad. Generic sterile injectable drugs — like chemotherapy medications and IV saline — are particularly vulnerable due to their complex manufacturing processes and low profit margins. Generic drugs (which account for 90 percent of prescriptions filled in the US) could face increased pressure, as many rely on raw materials from China and India. This could result in more severe drug shortages in the future. 
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 3813

    https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities

    #PharmaFlow by PHARMACOMPASS
    22 May 2025
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more

    Global Sales Information

    Do you need Business Intel? Ask us

    Regulatory FDF Prices

    read-more
    read-more

    01

    Brand Name : Rifater

    France
    arrow
    AES
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RX/OTC/DISCN : Class A

    SANOFI SpA

    Isoniazid; Pyrazinamide; Rifampicin

    Dosage Form : Isoniazid+Pyrazinamide+Rifampici...

    Dosage Strength : 40 cpr riv 50 mg + 300mg + 120 mg

    Price Per Pack (Euro) : 10.57

    Published in :

    Country : Italy

    RX/OTC/DISCN : Class A

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Rifadin

    France
    arrow
    AES
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RX/OTC/DISCN : Class A

    SANOFI SpA

    Rifampicin

    Dosage Form : Rifampicin 2% 60Ml Oral Use

    Dosage Strength : 1 bottle 60 ml 20 mg/ml syrup

    Price Per Pack (Euro) : 2.8

    Published in :

    Country : Italy

    RX/OTC/DISCN : Class A

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Rifadin

    France
    arrow
    AES
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RX/OTC/DISCN : Class A

    SANOFI SpA

    Rifampicin

    Dosage Form : Rifampicin 300Mg 8 Joined' Oral ...

    Dosage Strength : 8 cps 300 mg

    Price Per Pack (Euro) : 3.72

    Published in :

    Country : Italy

    RX/OTC/DISCN : Class A

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Rifadin

    France
    arrow
    AES
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RX/OTC/DISCN : Class A

    SANOFI SpA

    Rifampicin

    Dosage Form : Rifampicin 450Mg 8 Joined' Oral ...

    Dosage Strength : 8 cpr riv 450 mg

    Price Per Pack (Euro) : 4.86

    Published in :

    Country : Italy

    RX/OTC/DISCN : Class A

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Rifadin

    France
    arrow
    AES
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RX/OTC/DISCN : Class A

    SANOFI SpA

    Rifampicin

    Dosage Form : Rifampicin 600Mg 1 Unit Parenter...

    Dosage Strength : 1 ampoule EV 600 mg + 1 ampoule solv 10 ml

    Price Per Pack (Euro) : 9.28

    Published in :

    Country : Italy

    RX/OTC/DISCN : Class A

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Rifinah

    France
    arrow
    AES
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RX/OTC/DISCN : Class A

    SANOFI SpA

    Rifampicin; Isoniazid

    Dosage Form : Rifampicin+Isoniazid+150300 Mg 2...

    Dosage Strength : 24 cpr riv 300 mg + 150 mg

    Price Per Pack (Euro) : 9.48

    Published in :

    Country : Italy

    RX/OTC/DISCN : Class A

    Sanofi Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Rimcure

    Switzerland
    arrow
    AES
    Not Confirmed

    Brand Name : Rimcure

    Switzerland
    arrow
    AES
    Not Confirmed

    Sandoz - Copenhagen

    Rifampicin

    Dosage Form : Antic-calc Tablet, Film Coated

    Dosage Strength : 150 mg/75 mg/400 mg

    Price Per Pack (Euro) : 49.302

    Published in :

    Country : Norway

    RX/OTC/DISCN :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Rimstar

    Switzerland
    arrow
    AES
    Not Confirmed

    Brand Name : Rimstar

    Switzerland
    arrow
    AES
    Not Confirmed

    Sandoz - Copenhagen

    Rifampicin

    Dosage Form : Antic-calc Tablet, Film Coated

    Dosage Strength : 150 mg/75 mg/400 mg/275 mg

    Price Per Pack (Euro) : 73.106

    Published in :

    Country : Norway

    RX/OTC/DISCN :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : Rimactan

    Switzerland
    arrow
    AES
    Not Confirmed

    Brand Name : Rimactan

    Switzerland
    arrow
    AES
    Not Confirmed

    Sandoz GmbH

    Rifampicin

    Dosage Form : Capsule, hard

    Dosage Strength : 150 mg

    Price Per Pack (Euro) : 56.694

    Published in :

    Country : Norway

    RX/OTC/DISCN :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Brand Name : Rimactan

    Switzerland
    arrow
    AES
    Not Confirmed

    Brand Name : Rimactan

    Switzerland
    arrow
    AES
    Not Confirmed

    Sandoz GmbH

    Rifampicin

    Dosage Form : Capsule, hard

    Dosage Strength : 150 mg

    Price Per Pack (Euro) : 56.694

    Published in :

    Country : Norway

    RX/OTC/DISCN :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Market Place

    Do you need sourcing support? Ask us

    APIs

    read-more
    read-more
    SouthAfrica.png
    Rifampicin (100 kg) API needed in South Africa [ENA23783]
    A company that focuses on the manufacturing of various finished formulations is looking for suppliers of Rifampicin (100 kg) API for commercial purposes. The suppliers must support this enquiry with CoA.
    18 Aug 2025

    Reply

    18 Aug 2025

    Reply text-arrow

    Reply Comment (5)

    18 Aug 2025

    india-flag.png
    Rifampicin API needed in India [ENA23285]
    A company that focuses on the manufacturing and development of various finished formulations and APIs is looking for suppliers of Rifampicin API for development purposes. The suppliers must support this enquiry with open part DMF & CoA.
    19 Jun 2025

    Reply

    19 Jun 2025

    Reply text-arrow

    Reply Comment (3)

    19 Jun 2025

    india-flag.png
    Rifampicin (25 kg - 50 kg) API needed in India [ENA23025]
    A company that focuses on the development & manufacturing of various finished formulations is looking for suppliers of Rifampicin (25 kg - 50 kg) API for commercial purposes. The suppliers must support this enquiry with CoA.
    22 May 2025

    Reply

    22 May 2025

    Reply text-arrow

    Reply Comment (1)

    22 May 2025

    Jordan.png
    Compacted & BP Grade Rifampicin (2 MT - 3 MT) API needed in Jordan [ENA19827]
    A company that focuses on development, manufacturing, marketing and distribution of various branded and generic pharmaceutical products is looking for suppliers of Compacted & BP Grade Rifampicin (2 MT - 3 MT) API for commercial purposes. The suppliers must support this enquiry with CoA.
    28 Jun 2024

    Reply

    28 Jun 2024

    Reply text-arrow

    Reply Comment (6)

    28 Jun 2024

    Iran.png
    USP and EP/ BP Rifampicin (MOQ) API needed in Iran [ENA19795]
    A company that focuses on manufacturing and distribution of a various own branded oral antibiotic-related & non-antibiotic products is looking for suppliers of USP and EP/ BP Rifampicin (MOQ) API for development purposes. The suppliers must support this enquiry with GMP & CoA.
    25 Jun 2024

    Reply

    25 Jun 2024

    Reply text-arrow

    Reply Comment (4)

    25 Jun 2024

    unitedkingdom_new.png
    Rifampicin (20 kg) API needed in United Kingdom [ENA18509]
    A company that deals in the distribution of various pharmaceutical products is looking for suppliers of Rifampicin (20 kg) API for commercial purposes. The suppliers must support this enquiry with GMP & CoA.
    01 Nov 2023

    Reply

    01 Nov 2023

    Reply text-arrow

    Reply Comment (10)

    01 Nov 2023

    india-flag.png
    IP Grade Rifampicin (1.5 MT) API needed in India [ENA18163]
    A company that focuses on the development & manufacturing of capsules, ointments, liquid orals and tablets is looking for suppliers of IP Grade Rifampicin (1.5 MT) API for commercial purposes. The suppliers must support this enquiry with CoA.
    27 Sep 2023

    Reply

    27 Sep 2023

    Reply text-arrow

    Reply Comment (1)

    27 Sep 2023

    Ukraine.png
    Rifampicin API needed in Ukraine [ENA17694]
    A company that focuses on research, development and manufacturing of injections, infusions, syrups & liquids is looking for suppliers of Rifampicin API. The initial required quantity is 1 kg for development & later 21 kg for commercial purposes. The suppliers must support this enquiry with CEP, DMF, GMP & CoA.
    28 Jul 2023

    Reply

    28 Jul 2023

    Reply text-arrow

    Reply Comment (5)

    28 Jul 2023

    india-flag.png
    Rifampicin (1 MT) API needed in India [ENA17572]
    A company that deals in various pharmaceutical products is looking for suppliers of Rifampicin (1 MT) API for commercial purposes. The suppliers must support this enquiry with CoA.
    17 Jul 2023

    Reply

    17 Jul 2023

    Reply text-arrow

    Reply Comment (5)

    17 Jul 2023

    Singapore.png
    Rifampin (100 g) API needed in Singapore [ENA17064]
    A clinical-stage biotechnological company that focuses on the research and development of ultra-sustained analgesic products is looking for suppliers of Rifampin (100 g) API for development purposes. The suppliers must support this enquiry with CoA.
    09 May 2023

    Reply

    09 May 2023

    Reply text-arrow

    Reply Comment (6)

    09 May 2023

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    FDF DOSSIERS

    read-more
    read-more
    india-flag.png
    Various Finished Formulations needed in India [ENA19513]
    A CMO which focuses on manufacturing and delivering branded, generic formulations and active pharmaceutical ingredients (API’s) of essential phospholipids to customers is looking for suppliers of Various Finished Formulations for commercial purposes. The required quantity is 2,00,000 Units. 1. Trimeperidine 2% Injection 2. Rifampicin (0.15 mg/ml) Injection
    14 May 2024

    Reply

    14 May 2024

    Reply text-arrow

    Reply Comment (2)

    14 May 2024

    Hungary.png
    Various Finished Dosage Formulations needed in Hungary [ENA18386]
    A pharmaceutical company that focuses on analytical testing, quality development activities, manufacturing & distribution of finished formulations is looking for suppliers of Various Finished Dosage Formulations for commercial purposes. The suppliers must support this enquiry with EUCTD dossier. 1. Rifampicin (150 mg or 300 mg) Capsules 2. Isoniazid (150 mg or 300 mg) Tablets 3. Pyrazinamide (400 mg or 500 mg or 750 mg) Tablets 4. Ethambutol (100 mg or 400 mg) Tablets 5. Propylthiouracil (50 mg) Tablets
    18 Oct 2023

    Reply

    18 Oct 2023

    Reply text-arrow

    Reply Comment (2)

    18 Oct 2023

    Sweden.png
    Tender// Various Finished Dosage Formulations needed in Sweden [ENA15389]
    Region Jonkoping County is looking for supplies of Various Finished Dosage Formulations for commercial purpose. The deadline is 15-Nov-2022. 1. Fidaxomicin (200 mg) Tablets. The required quantity is 2,920 units. 2. Clonidine (150 mcg/ ml) Injections. The required quantity is 11,330 units. 3. Rifampicin (300 mg) Capsules. The required quantity is 24,200 units. 4. Mepivacaine (10 mg/ ml) Injections. The required quantity is 13,600 units.
    21 Oct 2022

    Reply

    21 Oct 2022

    Reply text-arrow

    Reply Comment (4)

    21 Oct 2022

    Bulgaria.png
    Tender// Various Finished Dosage Formulations needed in Bulgaria [ENA11442]
    Mnogoprofilna Bolnitsa Za Aktivno Lechenie - SV. Ivan Rilski Eood is looking for supplies of Various Finished Dosage Formulations for commercial purpose. The deadline is 19-Oct-2021. 1. Metamizole Sodium (500 mg/ ml in 2 ml) Solution for Injection. The required quantity is 10,000 units. 2. Metoclopramide (10 mg in 2 ml) Solution for Injection. The required quantity is 16,000 units. 3. Nadroparin (3800 IU) Solution for Injection. The required quantity is 12,000 units. 4. Paracetamol (500 mg) Tablets. The required quantity is 12,000 units. 5. Paracetamol (10 mg/ ml in 10 ml) Solution for Infusion. The required quantity is 30,000 units. 6. Phenobarbital (100 mg/ ml in 2 ml) Solution for Injection. The required quantity is 3,200 units. 7. Piracetam (3 g/ 15 ml) Solution for Injection. The required quantity is 10,000 units. 8. Rifampicin (300 mg) Capsules. The required quantity is 3,000 units. 9. Silymarin (110 mg) Hard Capsules. The required quantity is 9,000 units. 10. Sodium Chloride (0.9% in 500 ml) Solution for Infusion. The required quantity is 30,000 units.
    20 Sep 2021

    Reply

    20 Sep 2021

    Reply text-arrow

    Reply Comment (4)

    20 Sep 2021

    Poland.png
    Tender// Various Finished Dosage Formulations needed in Poland [ENA11359]
    Provincial Specialist Hospital for them st. Rafal in Czerwona Gora is looking for supplies of Various Finished Dosage Formulations for commercial purpose. The deadline is 11-Oct-2021. 1. Ciprofloxacin (0.5 g) Tablets. The required quantity is 5,370 units. 2. Cefuroxime (1.5 g) Injections. The required quantity is 6,010 units. 3. Ceftriaxone (1 g) Injections. The required quantity is 6,240 units. 4. Cefotaxime (1 g) Injections. The required quantity is 35,120 units. 5. Ceftazidime (1 g) Intravenous and Intramuscular Injection and Infusion. The required quantity is 5,930 units. 6. Budesonide (0.4 g) Capsules for Inhalation. The required quantity is 3,120 units. 7. Amiodarone (0.15 g/ 3 ml) Ampoules. The required quantity is 2,970 units. 8. Acetylsalicylic Acid (0.075 g) Tablets. The required quantity is 12,960 units. 9. Lidocaine (2% of 0.2 g/ 10 ml) Ampoules. The required quantity is 10,220 units. 10. Bupivacaine (0.5% of 0.02 g/ 4 ml) Ampoules. The required quantity is 1,740 units. 11. Rifampicin (0.3 g) + Isoniazid (0.15 g) Capsules. The required quantity is 13,100 units. 12. Metronidazole (0.25 g) Tablets. The required quantity is 6,280 units. 13. Fentanyl (0.1 mg/ 2 ml) Ampoules. The required quantity is 6,500 units. 14. Amikacin (0.5 g/ 2 ml) Ampoules. The required quantity is 1,757 units.
    10 Sep 2021

    Reply

    10 Sep 2021

    Reply text-arrow

    Reply Comment (4)

    10 Sep 2021

    Ukraine.png
    Tender// Various Finished Dosage Formulations needed in Ukraine [ENA11134]
    UNDP is looking for supplies of Various Finished Dosage Formulations for children suffering from primary (congenital) Immunodeficiency. The deadline is 30-Aug-2021. 1. Human Chorionic Gonadotropin (5,000 IU) Powder for Solution for Injection 2. Menotropin (75 IU) Lyophilized Powder for Solution for Injection 3. Risperidone (1 mg/ ml) Oral Solution 4. Rifampicin (600 mg) Ampoules, Vials and Syringes 5. Levofloxacin (5 mg/ ml) Ampoules, Vials and Syringes 6. Amoxicillin and Clavulanic Acid (1,000 mg/ 200 mg) Ampoules, Vials and Syringes 7. Amoxicillin and Clavulanic Acid (125 mg/ 31.25 mg in 5 ml) Powder for Oral Suspension 8. Amikacin (1,000 mg) Ampoules, Vials and Syringes 9. Voriconazole (50 mg) Tablets 10. Sirolimus (1 mg) Tablets 11. Esterase Inhibitor (Human) Lyophilizate for preparation of Solution for Intravenous administration 500 IU 12. Filgrastim (300 mcg/ ml) Solution for Injection
    17 Aug 2021

    Reply

    17 Aug 2021

    Reply text-arrow

    Reply Comment (7)

    17 Aug 2021

    Bulgaria.png
    Tender// Various Finished Dosage Formulations needed in Bulgaria [ENA10185]
    Specialized Hospital for Active Treatment of Infectious and Parasitic Diseases "Prof. Ivan Kirov" EAD is looking for supplies of Various Finished Dosage Formulations. The deadline is 8-May-2021. 1. Ceftriaxone (2 g and 1 g) Powder for Injection. The required quantity is 20,000 units and 4,000 units respectively. 2. Cefuroxime (500 mg) Filmed Tablets. The required quantity is 1,000 units. 3. Ceftazidime (1 g) Powder for Injection. The required quantity is 2,000 units. 4. Cefoperazone (1g) Powder for Injection. The required quantity is 2,500 units. 5. Azithromycin (500 mg) Film-Coated Tablets. The required quantity is 6,000 units. 6. Azithromycin (500 mg) Powdered Infusion Solution. The required quantity is 1,000 units. 7. Ciprofloxacin (400 mg/ 200 ml and 10 mg/ 10 ml) Concentrated Infusion Solution. The required quantity is 800 units and 3,120 units respectively. 8. Levofloxacin (5 mg/ ml in 100 ml) Solution for Infusion. The required quantity is 8,000 units. 9. Rifampicin (300 mg) Capsules. The required quantity is 1,000 units. 10. Ethambutol (250 mg) Tablets. The required quantity is 2,000 units.
    12 Apr 2021

    Reply

    12 Apr 2021

    Reply text-arrow

    Reply Comment (6)

    12 Apr 2021

    Market Place
    Enquiry// Various anti-tuberculosis drugs needed for government tender business in Nepal [ENA01762]
    A trading company is looking for suppliers of the following anti-tuberculosis finished formulations for government tender businnes in Nepal: 1) Rifampicin 150mg/ Isoniazid 75mg (film-coated tablet) 2) Rifampicin 150mg/ Isoniazid 75mg/ Ethambutol 275mg (film-coated tablet) 3) Rifampicin 150 mg/ Isoniazid 75mg/ Pyrazinamide 400mg (film-coated tablet) 4) Isoniazid 100mg (dispersible tablet) 5) Ethambutol 100mg (dispersible tablet) 6) Rifampicin 75 mg/ Isoniazid 50mg/ Pyrazinamide 150mg (dispersible tablet) 7) Rifampicin 75 mg/ Isoniazid 50mg/ Pyrazinamide 150mg (dispersible tablet) Interested suppliers must support this enquiry with WHO-GMP certificate.
    04 Sep 2018

    Reply

    04 Sep 2018

    Reply text-arrow

    Reply Comment (5)

    04 Sep 2018

    Market Place
    Enquiry// Rifampicin Capsules (150mg) 100 units needed in Botswana [ENA01523]
    An intensively growing pharmaceutical company based in Botswana, is looking for the suppliers of Rifampicin Capsules (150mg) 100 units. Interested suppliers must support this enquiry with the following specifications: 1) Valid cGMP certificates 2) Certificate of Analysis 3) WHO certificate of Pharmaceutical Product or Equivalent 4) Valid Certification of USFDA, MHRA and ICH 5) Bioequivalence and Stability Data of Finished Product
    17 Aug 2018

    Reply

    17 Aug 2018

    Reply text-arrow

    Reply Comment (3)

    17 Aug 2018

    PharmaCompass
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    EDQM

    read-more
    read-more

    01

    EDQM, Council of Europe

    Rifampicin quinone

    arrow
    AES
    Not Confirmed

    01

    EDQM, Council of Europe

    France
    arrow
    AES
    Not Confirmed

    Rifampicin quinone

    CAS Number : 13983-13-6

    Quantity Per Vial : 100 mg

    Sale Unit : 1

    Order Code : R0800000

    Batch No : 4

    Price (€) : 79

    Storage : +5°C ± 3°C

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    EDQM, Council of Europe

    Rifampicin

    arrow
    AES
    Not Confirmed

    02

    EDQM, Council of Europe

    France
    arrow
    AES
    Not Confirmed

    Rifampicin

    CAS Number : 13292-46-1

    Quantity Per Vial : 100 mg

    Sale Unit : 1

    Order Code : R0700000

    Batch No : 2

    Price (€) : 79

    Storage : +5°C ± 3°C

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Others

    read-more
    read-more

    01

    Sigma-Aldrich Corporation

    U.S.A
    arrow
    Cell Bio
    Booth #824
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Rifampin

    CAS Number : 13292-46-1

    Quantity Per Vial :

    Sale Unit :

    Price : $310.00

    Details :

    Monograph : PHR1806-500MG

    Storage : +2°C to +8°C

    Code/Batch No :

    Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Sigma-Aldrich Corporation

    U.S.A
    arrow
    Cell Bio
    Booth #824
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothSigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Rifamycin Sodium

    CAS Number : 14897-39-3

    Quantity Per Vial :

    Sale Unit :

    Price : $159.00

    Details :

    Monograph : PHR1664-500MG

    Storage : -10°C to -25°C

    Code/Batch No :

    Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Akili Interactive Labs, Inc

    U.S.A
    arrow
    AES
    Not Confirmed

    Akili Interactive Labs, Inc

    U.S.A
    arrow
    AES
    Not Confirmed

    CAS Number :

    Quantity Per Vial :

    Sale Unit :

    Price : $310.00

    Details :

    Monograph : PHR1806-500MG

    Storage : +2?C to +8?C

    Code/Batch No :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Aozeal Certified Standards

    U.S.A
    arrow
    AES
    Not Confirmed

    Aozeal Certified Standards

    U.S.A
    arrow
    AES
    Not Confirmed

    Rifampicin Impurity 1

    CAS Number : 17555-51-0

    Quantity Per Vial :

    Sale Unit :

    Price :

    Details : In stock

    Monograph :

    Storage :

    Code/Batch No : R0012.10

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    XYZ Pharma

    Gabon
    arrow
    AES
    Not Confirmed

    XYZ Pharma

    Gabon
    arrow
    AES
    Not Confirmed

    Rifampin Quinone (25 mg) (1,4-dideoxy-1,4- di...

    CAS Number : 13983-13-6

    Quantity Per Vial : 25

    Sale Unit : mg

    Price : $775.00

    Details : Material Origin- Chemical Synthesis; USMCA- N...

    Monograph :

    Storage :

    Code/Batch No : Catalog #1604202 / R109W 0

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    XYZ Pharma

    Gabon
    arrow
    AES
    Not Confirmed

    XYZ Pharma

    Gabon
    arrow
    AES
    Not Confirmed

    Rifampin (300 mg)

    CAS Number : 13292-46-1

    Quantity Per Vial : 300

    Sale Unit : mg

    Price : $245.00

    Details : Material Origin- Fermentation- Chemical Synth...

    Monograph :

    Storage :

    Code/Batch No : Catalog #1604009 / R124W 0

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    XYZ Pharma

    Gabon
    arrow
    AES
    Not Confirmed

    XYZ Pharma

    Gabon
    arrow
    AES
    Not Confirmed

    Rifampin-N-Oxide (25 mg)

    CAS Number : 125833-03-6

    Quantity Per Vial : 25

    Sale Unit : mg

    Price : $630.00

    Details : Material Origin- Fermentation- Chemical Synth...

    Monograph :

    Storage :

    Code/Batch No : Catalog #1604199 / F120C0

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    ABOUT THIS PAGE

    Looking for / Rifampicin API manufacturers, exporters & distributors?

    Rifampicin manufacturers, exporters & distributors 1

    96

    PharmaCompass offers a list of Rifampicin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Rifampicin manufacturer or Rifampicin supplier for your needs.

    Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Rifampicin manufacturer or Rifampicin supplier.

    PharmaCompass also assists you with knowing the Rifampicin API Price utilized in the formulation of products. Rifampicin API Price is not always fixed or binding as the Rifampicin Price is obtained through a variety of data sources. The Rifampicin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

    API | Excipient name

    Rifampicin

    Rifampicin Manufacturers

    A Rifampicin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rifampicin, including repackagers and relabelers. The FDA regulates Rifampicin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rifampicin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

    click here to find a list of Rifampicin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

    Rifampicin Suppliers

    A Rifampicin supplier is an individual or a company that provides Rifampicin active pharmaceutical ingredient (API) or Rifampicin finished formulations upon request. The Rifampicin suppliers may include Rifampicin API manufacturers, exporters, distributors and traders.

    click here to find a list of Rifampicin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

    Rifampicin USDMF

    A Rifampicin DMF (Drug Master File) is a document detailing the whole manufacturing process of Rifampicin active pharmaceutical ingredient (API) in detail. Different forms of Rifampicin DMFs exist exist since differing nations have different regulations, such as Rifampicin USDMF, ASMF (EDMF), JDMF, CDMF, etc.

    A Rifampicin DMF submitted to regulatory agencies in the US is known as a USDMF. Rifampicin USDMF includes data on Rifampicin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Rifampicin USDMF is kept confidential to protect the manufacturer’s intellectual property.

    click here to find a list of Rifampicin suppliers with USDMF on PharmaCompass.

    Rifampicin JDMF

    The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

    The Rifampicin Drug Master File in Japan (Rifampicin JDMF) empowers Rifampicin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

    PMDA reviews the Rifampicin JDMF during the approval evaluation for pharmaceutical products. At the time of Rifampicin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

    click here to find a list of Rifampicin suppliers with JDMF on PharmaCompass.

    Rifampicin KDMF

    In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

    Pharmaceutical companies submit a Rifampicin Drug Master File in Korea (Rifampicin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Rifampicin. The MFDS reviews the Rifampicin KDMF as part of the drug registration process and uses the information provided in the Rifampicin KDMF to evaluate the safety and efficacy of the drug.

    After submitting a Rifampicin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Rifampicin API can apply through the Korea Drug Master File (KDMF).

    click here to find a list of Rifampicin suppliers with KDMF on PharmaCompass.

    Rifampicin CEP

    A Rifampicin CEP of the European Pharmacopoeia monograph is often referred to as a Rifampicin Certificate of Suitability (COS). The purpose of a Rifampicin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Rifampicin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Rifampicin to their clients by showing that a Rifampicin CEP has been issued for it. The manufacturer submits a Rifampicin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Rifampicin CEP holder for the record. Additionally, the data presented in the Rifampicin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Rifampicin DMF.

    A Rifampicin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Rifampicin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

    click here to find a list of Rifampicin suppliers with CEP (COS) on PharmaCompass.

    Rifampicin WC

    A Rifampicin written confirmation (Rifampicin WC) is an official document issued by a regulatory agency to a Rifampicin manufacturer, verifying that the manufacturing facility of a Rifampicin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Rifampicin APIs or Rifampicin finished pharmaceutical products to another nation, regulatory agencies frequently require a Rifampicin WC (written confirmation) as part of the regulatory process.

    click here to find a list of Rifampicin suppliers with Written Confirmation (WC) on PharmaCompass.

    Rifampicin NDC

    National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Rifampicin as an active pharmaceutical ingredient (API).

    Finished drug products

    The FDA updates the NDC directory daily. The NDC numbers for Rifampicin API and other APIs are published in this directory by the FDA.

    Unfinished drugs

    The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

    Pharmaceutical companies that manufacture Rifampicin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

    Compounded drug products

    The NDC directory also contains data on finished compounded human drug products that contain Rifampicin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Rifampicin NDC to their finished compounded human drug products, they may choose to do so.

    click here to find a list of Rifampicin suppliers with NDC on PharmaCompass.

    Rifampicin GMP

    Rifampicin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

    GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

    PharmaCompass offers a list of Rifampicin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Rifampicin GMP manufacturer or Rifampicin GMP API supplier for your needs.

    Rifampicin CoA

    A Rifampicin CoA (Certificate of Analysis) is a formal document that attests to Rifampicin's compliance with Rifampicin specifications and serves as a tool for batch-level quality control.

    Rifampicin CoA mostly includes findings from lab analyses of a specific batch. For each Rifampicin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

    Rifampicin may be tested according to a variety of international standards, such as European Pharmacopoeia (Rifampicin EP), Rifampicin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Rifampicin USP).

    Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
    For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search